Chemical name	SMILES	Class	Data set
"1,1,1-trichloroethane"	C(C)(Cl)(Cl)Cl	positive	training
"1,1,2-trichloroethane"	C(CCl)(Cl)Cl	positive	training
"1,1-dimethylhydrazine"	N(N)(C)C	positive	training
"1,3-dichloropropene"	C(=C\CCl)/Cl	positive	training
1-naphthylisothiocyanate	S=C=Nc1c2c(ccc1)cccc2	positive	external
"2,4,6-trinitrotoluene"	c1(c(cc(cc1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])C	positive	training
"2,4-dinitrophenol"	c1(c(cc(cc1)[N+](=O)[O-])[N+](=O)[O-])O	positive	training
2-ethoxyethanol	O(CCO)CC	positive	external
2-naphthol	Oc1cc2c(cc1)cccc2	positive	training
2-nitropropane	O=N(=O)C(C)C	positive	training
Abacavir	OC[C@H]1C[C@@H](n2c3nc(nc(NC4CC4)c3nc2)N)C=C1	positive	training
Abarelix	Clc1ccc(C[C@@H](NC(=O)[C@H](NC(=O)C)Cc2cc3c(cc2)cccc3)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@H](C)C(=O)N)CCCCNC(C)C)CC(C)C)CC(=O)N)Cc2ccc(O)cc2)C)CO)Cc2cccnc2)cc1	positive	external
Acamprosate	S(=O)(=O)(O)CCCNC(=O)C	negative	training
Acarbose	O([C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]1CO)O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)O)[C@H]1O[C@@H]([C@@H](N[C@@H]2[C@H](O)[C@@H](O)[C@H](O)C(=C2)CO)[C@H](O)[C@H]1O)C	positive	training
Acebutolol	O(C[C@@H](O)CNC(C)C)c1c(cc(NC(=O)CCC)cc1)C(=O)C	positive	external
Acemetacin	Clc1ccc(C(=O)n2c(c(c3c2ccc(OC)c3)CC(=O)OCC(=O)O)C)cc1	positive	training
Acetaminophen	Oc1ccc(NC(=O)C)cc1	positive	training
Acetazolamide	S(=O)(=O)(N)c1sc(NC(=O)C)nn1	negative	training
Acetohydroxamic	ONC(=O)C	negative	pairs
Acetone cyanohydrin	OC(C)(C)C#N	positive	training
Acetophenazine	S1c2c(N(CCCN3CCN(CC3)CCO)c3c1cccc3)cc(cc2)C(=O)C	positive	training
Acetylcholine	O(CC[N+](C)(C)C)C(=O)C	negative	black|NE
Acetylcysteine	SC[C@H](NC(=O)C)C(=O)O	positive	training
Acitretin	O(c1c(c(c(c(c1)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C)C)C)C	positive	black|NE
Aclarubicin	O([C@H]1C[C@@](O)([C@@H](c2c1c(O)c1c(c2)C(=O)c2c(C1=O)c(O)ccc2)C(=O)OC)CC)[C@@H]1O[C@H]([C@@H](O[C@@H]2O[C@H]([C@@H](O[C@@H]3O[C@H](C(=O)CC3)C)[C@@H](O)C2)C)[C@@H](N(C)C)C1)C	positive	training
Acyclovir	O(Cn1c2[nH]c(nc(=O)c2nc1)N)CCO	positive	training
Adapalene	O(c1c([C@]23C[C@@H]4C[C@H](C2)C[C@H](C3)C4)cc(cc1)c1cc2c(cc1)cc(cc2)C(=O)O)C	negative	training
Adefovir dipivoxil	P(=O)(OCOC(=O)C(C)(C)C)(OCOC(=O)C(C)(C)C)COCCn1c2ncnc(N)c2nc1	positive	training
Adenosine	O1[C@@H](n2c3ncnc(N)c3nc2)[C@H](O)[C@H](O)[C@H]1CO	negative	pairs
Afelimomab	O(c1c(/C=C/2\CCCN=C2c2cccnc2)ccc(OC)c1)C	positive	training
Alacepril	S(C[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C)C(=O)C	positive	training
Albendazole	S(c1cc2[nH]c(nc2cc1)NC(=O)OC)CCC	positive	training
Albuterol	O[C@@H](CNC(C)(C)C)c1cc(c(O)cc1)CO	negative	training
Alclometasone	Cl[C@H]1[C@H]2[C@H]3[C@@]([C@](O)([C@@H](C3)C)C(=O)CO)(C[C@H](O)[C@@H]2[C@@]2(C(=CC(=O)C=C2)C1)C)C	negative	training
Aldrin	Cl[C@@]12[C@H]3[C@@H]([C@@](Cl)(C1(Cl)Cl)C(=C2Cl)Cl)[C@H]1C[C@@H]3C=C1	positive	training
Alendronate	P(=O)(O)(O)C(P(=O)(O)O)(O)CCCN	positive	training
Alfentanil	O(C[C@]1(N(c2ccccc2)C(=O)CC)CCN(CC1)CCn1nnn(c1=O)CC)C	negative	training
Alfuzosin	O1[C@@H](CCC1)C(=O)NCCCN(c1nc2c(c(n1)N)cc(OC)c(OC)c2)C	positive	training
Alitretinoin	OC(=O)/C=C(/C=C/C=C(\C=C\C1=C(CCCC1(C)C)C)/C)\C	positive	training
Allopurinol	O=c1ncnc2[nH][nH]cc12	positive	training
Almitrine	Fc1ccc([C@H](N2CCN(CC2)c2nc(nc(n2)NCC=C)NCC=C)c2ccc(F)cc2)cc1	positive	training
Almotriptan	S(=O)(=O)(N1CCCC1)Cc1cc2c(CCN(C)C)c[nH]c2cc1	negative	training
Alosetron	O=C1N(CCc2n(c3c(c12)cccc3)C)Cc1nc[nH]c1C	negative	training
Alpidem	Clc1cn2c(CC(=O)N(CCC)CCC)c(nc2cc1)c1ccc(Cl)cc1	positive	training
Alprazolam	Clc1cc2c(n3c(nnc3C)CN=C2c2ccccc2)cc1	positive	training
Alprostadil	O[C@H]1[C@@H]([C@@H](CCCCCCC(=O)O)C(=O)C1)/C=C/[C@@H](O)CCCCC	positive	training
Altretamine	N(c1nc(N(C)C)nc(N(C)C)n1)(C)C	positive	training
Alvimopan	Oc1cc([C@]2([C@H](CN(CC2)C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)C)C)ccc1	positive	training
Amantadine	N[C@@]12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3	positive	training
Ambenonium	Clc1c(C[N+](CCNC(=O)C(=O)NCC[N+](Cc2c(Cl)cccc2)(CC)CC)(CC)CC)cccc1	negative	training
Ambrisentan	O([C@@]([C@H](Oc1nc(cc(n1)C)C)C(=O)O)(c1ccccc1)c1ccccc1)C	positive	training
Amcinonide	F[C@@]12[C@H]([C@H]3[C@@]([C@@]4(OC5(O[C@@H]4C3)CCCC5)C(=O)COC(=O)C)(C[C@@H]1O)C)CCC1=CC(=O)C=C[C@]21C	negative	training
Amdinocillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2/N=C/N1CCCCCC1	positive	external
Amifostine	S(P(=O)(O)O)CCNCCCN	negative	training
Amikacin	O([C@H]1[C@H](NC(=O)[C@@H](O)CCN)C[C@H](N)[C@@H](O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CN)[C@@H]1O)[C@H]1O[C@@H]([C@@H](O)[C@H](N)[C@H]1O)CO	positive	training
Amineptine	OC(=O)CCCCCCN[C@H]1c2c(CCc3c1cccc3)cccc2	positive	training
Aminocaproic acid	OC(=O)CCCCCN	positive	training
Aminoglutethimide	O=C1NC(=O)CC[C@@]1(CC)c1ccc(N)cc1	positive	training
Aminohippuric acid	O=C(NCC(=O)O)c1ccc(N)cc1	negative	training
Aminolevulinic acid	O=C(CCC(=O)O)CN	positive	training
Aminosalicylic acid	Oc1c(ccc(N)c1)C(=O)O	positive	training
Amiodarone	Ic1c(OCCN(CC)CC)c(I)cc(C(=O)c2c(oc3c2cccc3)CCCC)c1	positive	training
Amithiozone	S=C(N/N=C/c1ccc(NC(=O)C)cc1)N	positive	training
Amitriptyline 	N(CC/C=C\1/c2c(CCc3c1cccc3)cccc2)(C)C	positive	training
Amlexanox	o1c2c(cc(C(C)C)cc2)c(=O)c2c1nc(N)c(c2)C(=O)O	negative	training
Ammonium lactate	O[C@@H](C)C(=O)O	negative	training
Amodiaquine	Clc1cc2nccc(Nc3cc(CN(CC)CC)c(O)cc3)c2cc1	positive	training
Amonafide	O=c1n(CCN(C)C)c(=O)c2c3c1cc(N)cc3ccc2	positive	training
Amoxapine	Clc1cc2C(=Nc3c(Oc2cc1)cccc3)N1CCNCC1	positive	training
Amoxicillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@H](N)c1ccc(O)cc1	positive	training
Amphetamine	N[C@@H](Cc1ccccc1)C	negative	pairs
Amphotericin b	O1[C@@]2(O)C[C@H](O)[C@H]([C@@H]1C[C@@H](O[C@@H]1O[C@@H]([C@@H](O)[C@H](N)[C@@H]1O)C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H]([C@@H](O)[C@H]([C@@H](OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C2)C)C)C)C(=O)O	positive	training
Ampicillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1	positive	training
Amprenavir	S(=O)(=O)(N(C[C@@H](O)[C@@H](NC(=O)O[C@H]1CCOC1)Cc1ccccc1)CC(C)C)c1ccc(N)cc1	negative	training
Amsacrine	S(=O)(=O)(Nc1cc(OC)c(Nc2c3c(nc4c2cccc4)cccc3)cc1)C	positive	training
Anagrelide	Clc1c2CN3C(=NC(=O)C3)Nc2ccc1Cl	negative	external
Anastrozole	n1(ncnc1)Cc1cc(C(C)(C)C#N)cc(C(C)(C)C#N)c1	positive	training
Anidulafungin	O[C@H]1[C@H](CN2[C@@H]1C(=O)N[C@H](O)[C@H](O)C[C@H](NC(=O)c1ccc(cc1)c1ccc(cc1)c1ccc(OCCCCC)cc1)C(=O)N[C@H](C(=O)N1[C@@H](C[C@@H](O)C1)C(=O)N[C@H](C(=O)N[C@H](C2=O)[C@H](O)C)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@H](O)C)C	positive	external
Aniracetam	O=C1N(CCC1)C(=O)c1ccc(OC)cc1	negative	training
Anisindione	O=C1[C@@H](C(=O)c2c1cccc2)c1ccc(OC)cc1	negative	training
Anisotropine	O([C@H]1C[C@@H]2[N+]([C@@H](CC2)C1)(C)C)C(=O)C(CCC)CCC	negative	training
Apomorphine	Oc1c2c3c4[C@H](N(CCc4ccc3)C)Cc2ccc1O	negative	training
Apraclonidine	Clc1c(NC2=NCCN2)c(Cl)cc(N)c1	negative	training
Aprepitant	Fc1ccc([C@H]2N(CCO[C@H]2O[C@@H](c2cc(cc(c2)C(F)(F)F)C(F)(F)F)C)Cc2[nH][nH]c(=O)n2)cc1	positive	training
Aprindine	N([C@H]1Cc2c(C1)cccc2)(CCCN(CC)CC)c1ccccc1	positive	training
Arbutamine	O[C@@H](CNCCCCc1ccc(O)cc1)c1cc(O)c(O)cc1	negative	training
Argatroban	S(=O)(=O)(N[C@H](C(=O)N1[C@H](C[C@@H](CC1)C)C(=O)O)CCCN=C(N)N)c1c2NC[C@H](Cc2ccc1)C	positive	training
Aripiprazole	Clc1c(N2CCN(CC2)CCCCOc2cc3NC(=O)CCc3cc2)cccc1Cl	negative	external
Aspirin	O(c1c(cccc1)C(=O)O)C(=O)C	positive	training
Atazanavir	O[C@H]([C@@H](NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc1ccccc1)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc1ccc(cc1)c1ncccc1	positive	training
Atenolol	O(C[C@@H](O)CNC(C)C)c1ccc(cc1)CC(=O)N	negative	training
Atomoxetine	O([C@H](CCNC)c1ccccc1)c1c(cccc1)C	positive	training
Atorvastatin	Fc1ccc(c2n(c(C(C)C)c(c2c2ccccc2)C(=O)Nc2ccccc2)CC[C@@H](O)C[C@@H](O)CC(=O)O)cc1	positive	training
Atovaquone	Clc1ccc([C@H]2CC[C@@H](CC2)C2=C(O)c3c(C(=O)C2=O)cccc3)cc1	positive	training
Atracurium	O(c1cc2[C@H]([N+](CCc2cc1OC)(CCC(=O)OCCCCCOC(=O)CC[N+]1([C@@H](c2c(CC1)cc(OC)c(OC)c2)Cc1cc(OC)c(OC)cc1)C)C)Cc1cc(OC)c(OC)cc1)C	negative	training
Atrazine	Clc1nc(NC(C)C)nc(NCC)n1	positive	training
Atropine	O([C@H]1C[C@@H]2N([C@@H](CC2)C1)C)C(=O)[C@@H](c1ccccc1)CO	negative	training
Azacitidine	O1[C@@H]([C@@H](O)[C@@H](O)[C@@H]1n1c(=O)nc(nc1)N)CO	positive	training
Azatadine	N1(CCC(=C2c3c(CCc4c2nccc4)cccc3)CC1)C	negative	training
Azathioprine	S(c1n(cnc1N(=O)=O)C)c1ncnc2nc[nH]c12	positive	training
Azelaic acid	OC(=O)CCCCCCCC(=O)O	negative	training
Azelastine	Clc1ccc(Cc2nn([C@H]3CCCN(CC3)C)c(=O)c3c2cccc3)cc1	negative	training
Azithromycin	O([C@@H]1[C@H]([C@H](O[C@@H]2O[C@H]([C@H](O)[C@](OC)(C2)C)C)[C@H](C(=O)O[C@@H]([C@@](O)([C@H](O)[C@H](N(C[C@@H](C[C@]1(O)C)C)C)C)C)CC)C)C)[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C	positive	training
Azlocillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCNC1=O)c1ccccc1	negative	training
Aztreonam	S(=O)(=O)(O)N1[C@H]([C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)/c2nc(sc2)N)C1=O)C	positive	external
Bacampicillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O[C@@H](OC(=O)OCC)C)C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1	negative	training
Bacitracin	S1C(=N[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H]([C@@H](CC)C)C(=O)N[C@H]2CCCCNC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCCN)[C@@H](CC)C)Cc2ccccc2)Cc2[nH]cnc2)CC(=O)O)CC(=O)N)CCC(=O)O)C1)[C@@H](N)[C@@H](CC)C	negative	training
Baclofen	Clc1ccc([C@@H](CC(=O)O)CN)cc1	positive	training
Balsalazide	O=C(NCCC(=O)O)c1ccc(N/N=C/2\C=C(C(=O)C=C2)C(=O)O)cc1	negative	training
Beclomethasone	Cl[C@@]12[C@H]([C@H]3[C@@]([C@](O)([C@H](C3)C)C(=O)CO)(C[C@@H]1O)C)CCC1=CC(=O)C=C[C@]21C	negative	black|NE
Benazepril	O=C1N(c2c(CC[C@@H]1N[C@@H](CCc1ccccc1)C(=O)OCC)cccc2)CC(=O)O	positive	training
Bendamustine	ClCCN(c1cc2nc(n(c2cc1)C)CCCC(=O)O)CCCl	negative	training
Bendroflumethiazide	S1(=O)(=O)N[C@@H](Nc2c1cc(S(=O)(=O)N)c(c2)C(F)(F)F)Cc1ccccc1	positive	training
Benoxaprofen	Clc1ccc(c2oc3c(n2)cc([C@@H](C)C(=O)O)cc3)cc1	positive	black|NE
Benoxinate	O(CCN(CC)CC)C(=O)c1cc(OCCCC)c(N)cc1	negative	external
Bentazepam	s1c2c(CCCC2)c2=C(NCC(=O)N=c12)c1ccccc1	positive	training
Bentiromide	O=C(Nc1ccc(cc1)C(=O)O)[C@@H](NC(=O)c1ccccc1)Cc1ccc(O)cc1	negative	training
Benzarone	o1c(c(c2c1cccc2)C(=O)c1ccc(O)cc1)CC	positive	training
Benzbromarone	Brc1cc(C(=O)c2c3c(oc2CC)cccc3)cc(Br)c1O	positive	training
Benzidine	Clc1cc(c2cc(Cl)c(/N=N/[C@@H](C(=O)Nc3ccccc3)C(=O)C)cc2)ccc1/N=N/[C@@H](C(=O)Nc1ccccc1)C(=O)C	positive	training
Benzoic acid	OC(=O)c1ccccc1	negative	pairs
Benzonatate	O(CCOCCOCCOCCOCCOC)CCOCCOCCOCCOC(=O)c1ccc(NCCCC)cc1	negative	training
Benzphetamine	N([C@@H](Cc1ccccc1)C)(Cc1ccccc1)C	negative	training
Benzquinamide	O([C@H]1[C@@H](CN2[C@@H](C1)c1c(CC2)cc(OC)c(OC)c1)C(=O)N(CC)CC)C(=O)C	negative	training
Benzthiazide	Clc1c(S(=O)(=O)N)cc2S(=O)(=O)N=C(Nc2c1)CSCc1ccccc1	negative	training
Bepridil	O(C[C@@H](N1CCCC1)CN(Cc1ccccc1)c1ccccc1)CC(C)C	positive	training
Beta-carotene	C1(CCCC(=C1/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C1=C(CCCC1(C)C)C)\C)\C)/C)/C)C)(C)C	negative	training
Betaine	OC(=O)C[N+](C)(C)C	negative	training
Betaxolol	O(CC1CC1)CCc1ccc(OC[C@@H](O)CNC(C)C)cc1	negative	external
Bethanechol	O([C@@H](C[N+](C)(C)C)C)C(=O)N	negative	external
Bethanidine	N(Cc1ccccc1)/C(=N/C)/NC	negative	training
Bexarotene	OC(=O)c1ccc(C(=C)c2cc3C(CCC(c3cc2C)(C)C)(C)C)cc1	positive	training
Bezafibrate	Clc1ccc(C(=O)NCCc2ccc(OC(C)(C)C(=O)O)cc2)cc1	positive	training
Bicalutamide	S(=O)(=O)(C[C@](O)(C)C(=O)Nc1cc(c(cc1)C#N)C(F)(F)F)c1ccc(F)cc1	positive	external
Bimatoprost	O[C@@H]1[C@@H]([C@H]([C@H](O)C1)/C=C/[C@@H](O)CCc1ccccc1)C/C=C\CCCC(=O)NCC	positive	training
Biperiden	O[C@@]([C@H]1[C@H]2C[C@@H](C1)C=C2)(CCN1CCCCC1)c1ccccc1	negative	training
Bisoprolol	O(C[C@@H](O)CNC(C)C)c1ccc(COCCOC(C)C)cc1	positive	training
Bitolterol	O[C@@H](CNC(C)(C)C)c1cc(OC(=O)c2ccc(cc2)C)c(OC(=O)c2ccc(cc2)C)cc1	negative	training
Bivalirudin	O=C(N1[C@@H](CCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)Cc1ccccc1)CCCNC(=N)N)CC(=O)N)CC(=O)O)Cc1ccccc1)CCC(=O)O)CCC(=O)O)[C@H](CC)C	negative	training
Bortezomib	O=C(N[C@H](CC(C)C)B(O)O)[C@H](NC(=O)c1nccnc1)Cc1ccccc1	positive	training
Bosentan	S(=O)(=O)(Nc1nc(nc(OCCO)c1Oc1c(OC)cccc1)c1ncccn1)c1ccc(C(C)(C)C)cc1	positive	black|NE
Bretylium	Brc1c(C[N+](CC)(C)C)cccc1	negative	training
Brimonidine	Brc1c(NC2=NCCN2)ccc2nccnc12	negative	training
Bromfenac	Brc1ccc(C(=O)c2c(N)c(CC(=O)O)ccc2)cc1	positive	black|NE
Bromocriptine	Brc1[nH]c2c3c(C4=C[C@@H](C(=O)N[C@@]5(O[C@]6(O)N([C@H](C(=O)N7[C@H]6CCC7)CC(C)C)C5=O)C(C)C)CN([C@@H]4Cc13)C)ccc2	negative	training
Bromodichloromethane	BrC(Cl)Cl	positive	training
Bromoform	BrC(Br)Br	positive	training
Brompheniramine	Brc1ccc([C@H](CCN(C)C)c2ncccc2)cc1	negative	black|NE
Bropirimine	Brc1c([nH]c(nc1=O)N)c1ccccc1	positive	training
Broxuridine	Brc1cn([C@@H]2O[C@@H]([C@@H](O)C2)CO)c(=O)[nH]c1=O	positive	training
Buclizine	Clc1ccc([C@H](N2CCN(CC2)Cc2ccc(C(C)(C)C)cc2)c2ccccc2)cc1	negative	training
Budesonide	O1[C@]2([C@@]3([C@H]([C@H]4[C@H]([C@@H](O)C3)[C@@]3(C(=CC(=O)C=C3)CC4)C)C[C@H]2O[C@H]1CCC)C)C(=O)CO	negative	training
Bumetanide	S(=O)(=O)(N)c1c(Oc2ccccc2)c(NCCCC)cc(c1)C(=O)O	positive	external
Bupivacaine	O=C(Nc1c(cccc1C)C)[C@H]1N(CCCC1)CCCC	positive	training
Buprenorphine	O1[C@@H]2[C@]34[C@]5(C[C@@H]([C@]2(OC)CC5)[C@](O)(C(C)(C)C)C)[C@H](N(CC3)CC2CC2)Cc2c4c1c(O)cc2	negative	training
Bupropion	Clc1cc(C(=O)[C@@H](NC(C)(C)C)C)ccc1	positive	training
Buspirone	O=C1N(C(=O)CC2(CCCC2)C1)CCCCN1CCN(CC1)c1ncccn1	negative	training
Busulfan	S(=O)(=O)(OCCCCOS(=O)(=O)C)C	positive	training
Butenafine	N(Cc1ccc(C(C)(C)C)cc1)(Cc1c2c(ccc1)cccc2)C	negative	training
Butoconazole	Clc1c(S[C@@H](CCc2ccc(Cl)cc2)Cn2ccnc2)c(Cl)ccc1	negative	training
Butorphanol	O[C@@]12[C@@]3(CCN([C@H]1Cc1c3cc(O)cc1)CC1CCC1)CCCC2	negative	training
Caffeine	O=c1n(c(=O)n(c2ncn(c12)C)C)C	negative	training
Calcifediol	OC(CCC[C@H]([C@@H]1[C@@]2([C@@H](CC1)/C(=C/C=C\1/C[C@@H](O)CCC1=C)/CCC2)C)C)(C)C	negative	training
Calcipotriene	O[C@@H](C1CC1)/C=C/[C@H]([C@@H]1[C@@]2([C@@H](CC1)/C(=C/C=C\1/C[C@@H](O)C[C@H](O)C1=C)/CCC2)C)C	negative	training
Calcitriol	OC(CCC[C@H]([C@@H]1[C@@]2([C@@H](CC1)/C(=C/C=C\1/C[C@@H](O)C[C@H](O)C1=C)/CCC2)C)C)(C)C	negative	training
Camphor	O=C1[C@@]2(C([C@@H](CC2)C1)(C)C)C	positive	training
Candesartan cilexetil	O(C1CCCCC1)C(=O)O[C@@H](OC(=O)c1c2n(Cc3ccc(cc3)c3c(cccc3)c3n[nH]nn3)c(OCC)nc2ccc1)C	positive	training
Capecitabine	Fc1cn([C@@H]2O[C@@H]([C@@H](O)[C@H]2O)C)c(=O)nc1NC(=O)OCCCCC	positive	training
Caprolactam	O=C1NCCCCC1	positive	training
Captafol	ClC(Cl)(SN1C(=O)[C@H]2[C@@H](CC=CC2)C1=O)C(Cl)Cl	positive	training
Captopril	SC[C@H](C(=O)N1[C@@H](CCC1)C(=O)O)C	positive	training
Carbachol	O(CC[N+](C)(C)C)C(=O)N	negative	training
Carbamazepine	O=C(N1c2c(C=Cc3c1cccc3)cccc2)N	positive	training
Carbenicillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@@H](c1ccccc1)C(=O)O	positive	training
Carbimazole	S=c1n(ccn1C(=O)OCC)C	positive	training
Carbinoxamine	Clc1ccc([C@H](OCCN(C)C)c2ncccc2)cc1	negative	training
Carboprost	O[C@@H]1[C@@H]([C@H]([C@H](O)C1)/C=C/[C@@](O)(CCCCC)C)C/C=C\CCCC(=O)O	negative	training
Carbutamide	S(=O)(=O)(NC(=O)NCCCC)c1ccc(N)cc1	positive	training
Carisoprodol	O(C[C@](CCC)(COC(=O)N)C)C(=O)NC(C)C	negative	training
Carmustine	ClCCN(N=O)C(=O)NCCCl	positive	external
Carprofen	Clc1cc2c3c([nH]c2cc1)cc([C@@H](C)C(=O)O)cc3	positive	training
Carteolol	O(C[C@@H](O)CNC(C)(C)C)c1c2CCC(=O)Nc2ccc1	negative	training
Carvedilol	O(c1c2c3c([nH]c2ccc1)cccc3)C[C@H](O)CNCCOc1c(OC)cccc1	positive	training
Caspofungin	O[C@@H]1[C@@H]2N(CC1)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1N(C[C@H](O)C1)C(=O)[C@H](NC(=O)[C@@H](NC(=O)CCCCCCCC[C@H](C[C@@H](CC)C)C)C[C@@H](O)[C@@H](NC2=O)NCCN)[C@H](O)C)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@H](O)CCN	positive	training
Cefaclor	ClC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(=O)O	positive	training
Cefadroxil	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c2ccc(O)cc2)C(=C(C1)C)C(=O)O	positive	training
Cefamandole	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](O)c2ccccc2)C(=C(C1)CSc1n(nnn1)C)C(=O)O	positive	training
Cefazolin	S1[C@@H]2N(C(=O)[C@H]2NC(=O)Cn2nnnc2)C(=C(C1)CSc1sc(nn1)C)C(=O)O	positive	training
Cefdinir	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\O)/c2nc(sc2)N)C(=C(C1)C=C)C(=O)O	positive	training
Cefditoren pivoxil	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=C(C1)/C=C\c1scnc1C)C(=O)OCOC(=O)C(C)(C)C	positive	training
Cefepime	S1[C@H]2N(C(=C(C[N+]3(CCCC3)C)C1)C(=O)O)C(=O)[C@H]2NC(=O)/C(=N\OC)/c1nc(sc1)N	positive	external
Cefixime	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N/OCC(=O)O)/c2nc(sc2)N)C(=C(C1)C=C)C(=O)O	positive	training
Cefmenoxime	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=C(C1)CSc1n(nnn1)C)C(=O)O	positive	training
Cefmetazole	S1[C@H]2N(C(=O)[C@@]2(OC)NC(=O)CSCC#N)C(=C(C1)CSc1n(nnn1)C)C(=O)O	positive	training
Cefodizime	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=C(C1)CSc1sc(c(n1)C)CC(=O)O)C(=O)O	positive	training
Cefonicid	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](O)c2ccccc2)C(=C(C1)CSc1n(nnn1)CS(=O)(=O)O)C(=O)O	positive	training
Cefoperazone	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](NC(=O)N2CCN(C(=O)C2=O)CC)c2ccc(O)cc2)C(=C(C1)CSc1n(nnn1)C)C(=O)O	positive	training
Ceforanide	S1[C@H]2N(C(=O)[C@H]2NC(=O)Cc2c(CN)cccc2)C(=C(C1)CSc1n(nnn1)CC(=O)O)C(=O)O	positive	training
Cefotaxime	S1[C@@H]2N(C(=O)[C@@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=C(C1)COC(=O)C)C(=O)O	positive	training
Cefotetan	S1[C@H]2N(C(=O)[C@@]2(OC)NC(=O)[C@H]2S/C(=C(/C(=O)N)\C(=O)O)/S2)C(=C(C1)CSc1n(nnn1)C)C(=O)O	positive	training
Cefotiam	S1[C@H]2N(C(=O)[C@H]2NC(=O)Cc2nc(sc2)N)C(=C(C1)CSc1n(nnn1)CCN(C)C)C(=O)O	positive	training
Cefoxitin	S1[C@H]2N(C(=O)[C@@]2(OC)NC(=O)Cc2sccc2)C(=C(C1)COC(=O)N)C(=O)O	positive	external
Cefpirome	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N/OC)/c2nc(sc2)N)C(=C(C1)C[n+]1c2CCCc2ccc1)C(=O)O	positive	training
Cefpodoxime proxetil	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=C(C1)COC)C(=O)O[C@@H](OC(=O)OC(C)C)C	negative	training
Cefprozil	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c2ccc(O)cc2)C(=C(C1)/C=C/C)C(=O)O	positive	training
Cefsulodin	S1[C@@H]2N(C(=O)[C@H]2NC(=O)[C@H](S(=O)(=O)O)c2ccccc2)C(=C(C1)C[n+]1ccc(cc1)C(=O)N)C(=O)O	positive	training
Ceftazidime	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC(C)(C)C(=O)O)/c2nc(sc2)N)C(=C(C1)C[n+]1ccccc1)C(=O)O	positive	training
Ceftibuten	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=C\CC(=O)O)/c2nc(sc2)N)C(=CC1)C(=O)O	positive	training
Ceftizoxime	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=CC1)C(=O)O	positive	training
Ceftriaxone	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2nc(sc2)N)C(=C(C1)CSc1n([nH]c(=O)c(=O)n1)C)C(=O)O	positive	training
Cefuroxime	S1[C@H]2N(C(=O)[C@H]2NC(=O)/C(=N\OC)/c2occc2)C(=C(C1)COC(=O)N)C(=O)O	positive	training
Celecoxib	S(=O)(=O)(N)c1ccc(n2nc(cc2c2ccc(cc2)C)C(F)(F)F)cc1	positive	training
Cephalexin	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c2ccccc2)C(=C(C1)C)C(=O)O	positive	training
Cephalothin	S1[C@H]2N(C(=O)[C@H]2NC(=O)Cc2sccc2)C(=C(C1)COC(=O)C)C(=O)O	positive	training
Cephapirin	S1[C@H]2N(C(=O)[C@H]2NC(=O)CSc2ccncc2)C(=C(C1)COC(=O)C)C(=O)O	positive	training
Cephradine	S1[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)C2=CCC=CC2)C(=C(C1)C)C(=O)O	positive	training
Cerivastatin	Fc1ccc(c2c(c(nc(c2/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)C(C)C)C(C)C)COC)cc1	positive	external
Ceruletide	S(=O)(=O)(Oc1ccc(C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)NCC(=O)N[C@@H](Cc2c3c([nH]c2)cccc3)C(=O)N[C@H](CCCC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N)cc1)O	negative	training
Cetirizine	Clc1ccc([C@H](N2CCN(CC2)CCOCC(=O)O)c2ccccc2)cc1	positive	external
Cetrorelix	Clc1ccc(C[C@@H](NC(=O)[C@H](NC(=O)C)Cc2cc3c(cc2)cccc3)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@H](C)C(=O)N)CCCN=C(N)N)CC(C)C)CCCNC(=O)N)Cc2ccc(O)cc2)CO)Cc2cccnc2)cc1	positive	training
Cevimeline	S1C[C@@]2(O[C@H]1C)[C@@H]1CCN(C2)CC1	positive	training
Chenodiol	O[C@H]1[C@H]2[C@H]3[C@@]([C@H](CC3)[C@@H](CCC(=O)O)C)(CC[C@@H]2[C@@]2([C@H](C1)C[C@H](O)CC2)C)C	positive	pairs
Chlorambucil	ClCCN(c1ccc(CCCC(=O)O)cc1)CCCl	positive	training
Chloramphenicol	ClC(Cl)C(=O)N[C@@H]([C@H](O)c1ccc(N(=O)=O)cc1)CO	positive	training
Chlorbenside	Clc1ccc(CSc2ccc(Cl)cc2)cc1	positive	training
Chlordecone	Cl[C@@]12[C@@]3(Cl)[C@]4(Cl)[C@@]5(Cl)[C@@](Cl)([C@@]1(Cl)C4(Cl)Cl)[C@]2(Cl)C(=O)[C@@]35Cl	positive	training
Chlordiazepoxide	Clc1cc2=C(N(O)C/C(=N/C)/N=c2cc1)c1ccccc1	positive	training
Chlorhexidine	Clc1ccc(N/C(=N/C(=N/CCCCCC/N=C(/N=C(/Nc2ccc(Cl)cc2)\N)\N)/N)/N)cc1	negative	training
Chlormethiazole	ClCCc1scnc1C	positive	external
Chlormezanone	Clc1ccc([C@H]2S(=O)(=O)CCC(=O)N2C)cc1	positive	external
Chloroform	ClC(Cl)Cl	positive	training
Chloroprocaine	Clc1c(C(=O)OCCN(CC)CC)ccc(N)c1	negative	training
Chloroquine	Clc1cc2nccc(N[C@@H](CCCN(CC)CC)C)c2cc1	negative	training
Chlorotoluene	ClCc1ccccc1	positive	training
Chlorotrianisene	Cl/C(=C(/c1ccc(OC)cc1)\c1ccc(OC)cc1)/c1ccc(OC)cc1	negative	training
Chloroxine	Clc1c2c(nccc2)c(O)c(Cl)c1	negative	training
Chlorphenesin	Clc1ccc(OC[C@H](O)CO)cc1	negative	training
Chlorpheniramine	Clc1ccc([C@H](CCN(C)C)c2ncccc2)cc1	negative	training
Chlorpromazine	Clc1cc2N(CCCN(C)C)c3c(Sc2cc1)cccc3	positive	training
Chlorpropamide	Clc1ccc(S(=O)(=O)NC(=O)NCCC)cc1	positive	training
Chlorprothixene	Clc1cc2/C(=C/CCN(C)C)/c3c(Sc2cc1)cccc3	positive	training
Chlortetracycline	Clc1c2[C@@](O)([C@H]3C[C@@H]4[C@](O)(C(=O)C3=C(O)c2c(O)cc1)C(=O)/C(=C(\O)/N)/C(=O)[C@H]4N(C)C)C	positive	training
Chlorthalidone	Clc1c(S(=O)(=O)N)cc([C@]2(O)NC(=O)c3c2cccc3)cc1	negative	training
Chlorzoxazone	Clc1cc2[nH]c(=O)oc2cc1	positive	external
Cholestyramine	Clc1ccc(C(=O)c2ccc(OC(C(=O)NCCS(=O)(=O)O)(C)C)cc2)cc1	negative	training
Ciclesonide	O1[C@]2([C@@]3([C@H]([C@H]4[C@H]([C@@H](O)C3)[C@@]3(C(=CC(=O)C=C3)CC4)C)C[C@H]2O[C@H]1C1CCCCC1)C)C(=O)COC(=O)C(C)C	negative	training
Ciclopirox	On1c(C2CCCCC2)cc(cc1=O)C	negative	black|NE
Cidofovir	P(=O)(O)(O)CO[C@@H](Cn1ccc(nc1=O)N)CO	negative	training
Cilnidipine	O(C(=O)C1=C(NC(=C([C@H]1c1cc(N(=O)=O)ccc1)C(=O)OC/C=C/c1ccccc1)C)C)CCOC	positive	training
Cilostazol	O(CCCCc1n(nnn1)C1CCCCC1)c1cc2CCC(=O)Nc2cc1	negative	training
Cimetidine	S(Cc1nc[nH]c1C)CCN/C(=N/C)/NC#N	positive	external
Cinacalcet	FC(F)(F)c1cc(CCCN[C@@H](c2c3c(ccc2)cccc3)C)ccc1	negative	training
Cinoxacin	O1c2cc3n(nc(c(=O)c3cc2OC1)C(=O)O)CC	positive	training
Ciprofibrate	ClC1(Cl)[C@@H](C1)c1ccc(OC(C)(C)C(=O)O)cc1	positive	training
Ciprofloxacin	Fc1c(N2CCNCC2)cc2n(C3CC3)cc(c(=O)c2c1)C(=O)O	positive	training
Cladribine	Clc1nc2n([C@@H]3O[C@@H]([C@@H](O)C3)CO)cnc2c(n1)N	positive	training
Clarithromycin	O([C@@H]1[C@H]([C@H](O[C@@H]2O[C@H]([C@H](O)[C@](OC)(C2)C)C)[C@H](C(=O)O[C@@H]([C@@](O)([C@H](O)[C@H](C(=O)[C@@H](C[C@]1(OC)C)C)C)C)CC)C)C)[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C	positive	training
Clemastine	Clc1ccc([C@](OCC[C@@H]2N(CCC2)C)(c2ccccc2)C)cc1	negative	training
Clevidipine	Clc1c([C@H]2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OCOC(=O)CCC)cccc1Cl	negative	training
Clidinium	O([C@H]1[C@@H]2CC[N@+](C1)(CC2)C)C(=O)[C@](O)(c1ccccc1)c1ccccc1	negative	training
Clindamycin	Cl[C@@H]([C@@H](NC(=O)[C@H]1N(C[C@@H](C1)CCC)C)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O)C	positive	training
Clobetasol	ClCC(=O)[C@]1(OC(=O)CC)[C@@]2([C@H]([C@H]3[C@](F)([C@@H](O)C2)[C@@]2(C(=CC(=O)C=C2)CC3)C)C[C@@H]1C)C	negative	external
Clocortolone	Cl[C@@]12[C@H]([C@H]3[C@@]([C@H]([C@@H](C3)C)C(=O)CO)(C[C@@H]1O)C)C[C@H](F)C1=CC(=O)C=C[C@]21C	negative	training
Clofarabine	Clc1nc2n([C@@H]3O[C@@H]([C@@H](O)[C@@H]3F)CO)cnc2c(n1)N	positive	training
Clofazimine	Clc1ccc(n2c3c(nc4c2cccc4)cc(Nc2ccc(Cl)cc2)/c(=N/C(C)C)/c3)cc1	positive	training
Clofibrate	Clc1ccc(OC(C)(C)C(=O)OCC)cc1	positive	training
Clometacin	Clc1ccc(C(=O)c2c3c(n(c2C)CC(=O)O)cc(OC)cc3)cc1	positive	training
Clomipramine	Clc1cc2N(CCCN(C)C)c3c(CCc2cc1)cccc3	positive	training
Clonazepam	Clc1c(C2=NCC(=O)Nc3c2cc(N(=O)=O)cc3)cccc1	positive	training
Clonidine	Clc1c(NC2=NCCN2)c(Cl)ccc1	positive	training
Clopidogrel	Clc1c([C@H](N2CCc3sccc3C2)C(=O)OC)cccc1	positive	training
Clorazepate	Clc1cc2C(=N[C@@H](C(=O)Nc2cc1)C(=O)O)c1ccccc1	positive	training
Clotiazepam	Clc1c(C2=NCC(=O)N(c3sc(cc23)CC)C)cccc1	positive	external
Clotrimazole	Clc1c([C@](n2ccnc2)(c2ccccc2)c2ccccc2)cccc1	positive	training
Clovoxamine	Clc1ccc(/C(=N/OCCN)/CCCCOC)cc1	positive	training
Cloxacillin	Clc1c(c2noc(c2C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(=O)O)(C)C)C)cccc1	positive	external
Clozapine	Clc1cc2NC(=c3c(=Nc2cc1)cccc3)N1CCN(CC1)C	positive	training
Coenzyme q10	O(C1=C(OC)C(=O)C(=C(C/C=C(/CC/C=C(/CC/C=C(/CC/C=C(/CC/C=C(/CC/C=C(/CC/C=C(/CC/C=C(/CC/C=C(/CCC=C(C)C)\C)\C)\C)\C)\C)\C)\C)\C)\C)C1=O)C)C	positive	training
Colchicine	O(c1c2c(CC[C@H](NC(=O)C)c3c2ccc(OC)c(=O)c3)cc(OC)c1OC)C	positive	training
Colistimethate sodium	S(=O)(=O)(O)CNCC[C@H]1NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CCCC[C@@H](CC)C)CCNCS(=O)(=O)O)[C@H](O)C)CCNCS(=O)(=O)O)CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(C)C)CC(C)C)CCNCS(=O)(=O)O)CCNCS(=O)(=O)O)[C@H](O)C	negative	training
Conivaptan	O=C(N1CCc2[nH]c(nc2c2c1cccc2)C)c1ccc(NC(=O)c2c(c3ccccc3)cccc2)cc1	negative	training
Corticotropin	S(CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)Cc1ccc(O)cc1)CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)Cc1ccccc1)C)CCC(=O)O)C)CO)CCC(=O)O)CC(=O)O)Cc1ccc(O)cc1)CCCNC(=N)N)CCCNC(=N)N)CCCCN)CCCCN)CCCCN)Cc1c2c([nH]c1)cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1[nH]cnc1)CCC(=O)O)C	negative	training
Cosyntropin	S(CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](N)CO)Cc1ccc(O)cc1)CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)O)Cc1ccc(O)cc1)CCCNC(=N)N)CCCNC(=N)N)CCCCN)CCCCN)CCCCN)Cc1c2c([nH]c1)cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1nc[nH]c1)CCC(=O)O)C	negative	training
Cresol	Oc1ccc(cc1)C	positive	training
Cromolyn	O(C[C@H](O)COc1c2c(oc(cc2=O)C(=O)O)ccc1)c1c2c(oc(cc2=O)C(=O)O)ccc1	negative	training
Crotamiton	O=C(N(c1c(cccc1)C)CC)/C=C/C	negative	training
Cyanocobalamin	P(=O)(O[C@H]1[C@@H](O)[C@H](O[C@@H]1CO)n1cnc2c1cc(c(c2)C)C)(O[C@@H](CNC(=O)CC[C@]1(/C/2=C(/C3=N/C(=C\C4=N/C(=C(\C5=N[C@](C(=N2)[C@@H]1CC(=O)N)([C@@]([C@@H]5CCC(=O)N)(CC(=O)N)C)C)/C)/[C@@]([C@H]4CCC(=O)N)(CC(=O)N)C)/C([C@H]3CCC(=O)N)(C)C)\C)C)C)O	negative	training
Cyclacillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)C1(N)CCCCC1	negative	training
Cyclizine	N1(CCN(CC1)C)[C@@H](c1ccccc1)c1ccccc1	positive	training
Cyclobenzaprine	N(CC/C=C\1/c2c(C=Cc3c1cccc3)cccc2)(C)C	positive	training
Cyclofenil	O(c1ccc(C(=C2CCCCC2)c2ccc(OC(=O)C)cc2)cc1)C(=O)C	positive	training
Cyclopentolate	OC1(CCCC1)[C@@H](c1ccccc1)C(=O)OCCN(C)C	negative	training
Cyclophosphamide	ClCCN(P1(=O)OCCCN1)CCCl	positive	training
Cycloserine	O1NC(=O)[C@@H](N)C1	positive	training
Cyclosporine	O[C@@H]([C@@H]1N(C(=O)[C@@H](N(C(=O)[C@@H](N(C(=O)[C@H](N(C(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H](NC1=O)CC)C)C)CC(C)C)C(C)C)C)CC(C)C)C)C)C)CC(C)C)C)CC(C)C)C)C(C)C)C)[C@@H](C/C=C/C)C	positive	training
Cyclothiazide	Clc1cc2N[C@H](NS(=O)(=O)c2cc1S(=O)(=O)N)[C@H]1[C@H]2C[C@@H](C1)C=C2	negative	training
Cyproheptadine	N1(CCC(=C2c3c(C=Cc4c2cccc4)cccc3)CC1)C	positive	training
Cyproterone	ClC1=C[C@@H]2[C@@H]([C@]3([C@@H]4[C@@H](C4)C(=O)C=C13)C)CC[C@]1([C@H]2CC[C@]1(O)C(=O)C)C	positive	training
Cysteamine	SCCN	positive	training
Cytarabine	O1[C@@H](n2ccc(nc2=O)N)[C@@H](O)[C@H](O)[C@H]1CO	positive	training
Dacarbazine	O=C(N)C1=NC=N/C/1=N\NN(C)C	positive	black|NE
Dactinomycin	O=C1N2[C@@H](CCC2)C(=O)N(CC(=O)N([C@@H](C(C)C)C(=O)O[C@@H]([C@@H](NC(=O)c2c3nc4c(C(=O)N[C@H]5C(=O)N[C@@H](C(=O)N6[C@@H](CCC6)C(=O)N(CC(=O)N([C@@H](C(C)C)C(=O)O[C@@H]5C)C)C)C(C)C)ccc(c4oc3c(c(=O)c2N)C)C)C(=O)N[C@@H]1C(C)C)C)C)C	positive	training
Danazol	O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=Cc5oncc5C4)CC3)C)CC2)CC1)C)C#C	positive	training
Dantrolene	o1c(c2ccc(N(=O)=O)cc2)ccc1/C=N/N1CC(=O)NC1=O	positive	black|NE
Dapiprazole	N1(CCN(CC1)c1c(cccc1)C)CCc1n2CCCCc2nn1	negative	training
Dapsone	S(=O)(=O)(c1ccc(N)cc1)c1ccc(N)cc1	positive	training
Daptomycin	O1[C@@H]([C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CCCCCCCCC)Cc2c3c([nH]c2)cccc3)CC(=O)N)CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@@H]([C@@H](CC(=O)O)C)C(=O)N[C@@H](CC(=O)c2c(N)cccc2)C1=O)CO)CC(=O)O)C)C	positive	training
Darifenacin	O=C(N)[C@]([C@@H]1CCN(C1)CCc1cc2c(OCC2)cc1)(c1ccccc1)c1ccccc1	negative	training
Dasatinib	Clc1c(NC(=O)c2sc(Nc3nc(nc(N4CCN(CC4)CCO)c3)C)nc2)c(ccc1)C	positive	training
Decitabine	O1[C@@H]([C@@H](O)C[C@@H]1n1c(=O)nc(nc1)N)CO	positive	training
Deferasirox	O=C1/C(=c\2/n([nH]/c(=C/3\C(=O)C=CC=C3)/[nH]2)c2ccc(cc2)C(=O)O)/C=CC=C1	positive	training
Deferiprone	Oc1c(n(ccc1=O)C)C	positive	training
Delapril	O=C(N([C@H]1Cc2c(C1)cccc2)CC(=O)O)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	positive	training
Delavirdine	S(=O)(=O)(Nc1cc2cc([nH]c2cc1)C(=O)N1CCN(CC1)c1ncccc1NC(C)C)C	positive	training
Demecarium	O(c1cc([N+](C)(C)C)ccc1)C(=O)N(CCCCCCCCCCN(C(=O)Oc1cc([N+](C)(C)C)ccc1)C)C	negative	training
Demeclocycline	Clc1c2[C@@H](O)[C@H]3C[C@@H]4[C@](O)(C(=O)C3=C(O)c2c(O)cc1)C(=O)/C(=C(/O)\N)/C(=O)[C@H]4N(C)C	positive	training
Deserpidine	O([C@@H]1[C@H]([C@@H]2[C@@H](CN3[C@H](C2)c2[nH]c4c(c2CC3)cccc4)C[C@H]1OC(=O)c1cc(OC)c(OC)c(OC)c1)C(=O)OC)C	negative	training
Desipramine	N1(c2c(CCc3c1cccc3)cccc2)CCCNC	positive	training
Deslanoside	O[C@@]12[C@H]3[C@@H]([C@@]4([C@H](CC3)C[C@@H](O[C@@H]3O[C@@H]([C@@H](O[C@@H]5O[C@@H]([C@@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)CO)[C@@H](O)C6)C)[C@@H](O)C5)C)[C@@H](O)C3)C)CC4)C)C[C@@H](O)[C@@]1([C@H](CC2)C1=CC(=O)OC1)C	negative	training
Desloratadine	Clc1cc2c(C(=C3CCNCC3)c3ncccc3CC2)cc1	positive	training
Desmopressin	S1SCCC(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)Cc1ccccc1)Cc1ccc(O)cc1	negative	training
Desonide	O1[C@]2([C@@]3([C@H]([C@H]4[C@H]([C@@H](O)C3)[C@@]3(C(=CC(=O)C=C3)CC4)C)C[C@H]2OC1(C)C)C)C(=O)CO	negative	external
Desoximetasone	F[C@@]12[C@H]([C@H]3[C@@]([C@H]([C@@H](C3)C)C(=O)CO)(C[C@@H]1O)C)CCC1=CC(=O)C=C[C@]21C	negative	training
Desvenlafaxine	OC1([C@@H](CN(C)C)c2ccc(O)cc2)CCCCC1	negative	training
Dexfenfluramine	FC(F)(F)c1cc(C[C@H](NCC)C)ccc1	positive	training
Dexibuprofen	OC(=O)[C@H](c1ccc(CC(C)C)cc1)C	positive	training
Dexlansoprazole	[S@@](=O)(Cc1nccc(OCC(F)(F)F)c1C)c1[nH]c2c(n1)cccc2	positive	training
Dexmedetomidine	[nH]1c([C@@H](c2c(c(ccc2)C)C)C)cnc1	negative	training
Dexmethylphenidate	O(C(=O)[C@@H]([C@@H]1NCCCC1)c1ccccc1)C	negative	pairs
Dexrazoxane	O=C1NC(=O)CN([C@H](CN2CC(=O)NC(=O)C2)C)C1	positive	training
Dextran	O1[C@@H]([C@H](O)[C@H](O)[C@H](O)[C@@H]1OC[C@H](O)[C@H](O)[C@H](O)[C@H](O)C=O)CO[C@H]1O[C@@H]([C@@H](O)[C@@H](O)[C@H]1O)CO	positive	training
Dextroamphetamine	N[C@H](Cc1ccccc1)C	negative	external
Dextromethorphan	O(c1cc2[C@@]34[C@@H]([C@H](N(CC3)C)Cc2cc1)CCCC4)C	negative	training
Dextrose	O1[C@@H]([C@@H](O)[C@H](O)[C@H](O)[C@@H]1O)CO	negative	training
Dextrothyroxine	Ic1cc(C[C@@H](N)C(=O)O)cc(I)c1Oc1cc(I)c(O)c(I)c1	negative	training
Dezocine	Oc1cc2[C@@]3([C@H](N)[C@H](Cc2cc1)CCCCC3)C	negative	training
Diacerein	O(c1c2c(C(=O)c3c(C2=O)c(OC(=O)C)ccc3)cc(c1)C(=O)O)C(=O)C	positive	external
Diatrizoate	Ic1c(NC(=O)C)c(I)c(c(I)c1NC(=O)C)C(=O)O	negative	training
Diazepam	Clc1cc2c(N(C(=O)CN=C2c2ccccc2)C)cc1	positive	training
Diaziquone	O=C1C(=C(NC(=O)OCC)C(=O)C(=C1NC(=O)OCC)N1CC1)N1CC1	positive	training
Diazoxide	Clc1cc2S(=O)(=O)N=C(Nc2cc1)C	positive	training
Dibromochloropropane	Br[C@@H](CBr)CCl	positive	external
Dibucaine	O(c1nc2c(c(C(=O)NCCN(CC)CC)c1)cccc2)CCCC	negative	training
Diclofenac	Clc1c(Nc2c(CC(=O)O)cccc2)c(Cl)ccc1	positive	training
Dicumarol	o1c(O)c(Cc2c(=O)c3c(oc2O)cccc3)c(=O)c2c1cccc2	negative	training
Dicyclomine	O(C(=O)C1(C2CCCCC2)CCCCC1)CCN(CC)CC	negative	training
Didanosine	O1[C@@H](n2c3[nH]cnc(=O)c3nc2)CC[C@H]1CO	positive	training
Dienestrol	Oc1ccc(/C(=C\C)/C(=C/C)/c2ccc(O)cc2)cc1	negative	training
Diethylcarbamazine	O=C(N1CCN(CC1)C)N(CC)CC	negative	training
Diethylpropion	O=C([C@H](N(CC)CC)C)c1ccccc1	negative	training
Diethylstilbestrol	Oc1ccc(/C(=C(\CC)/c2ccc(O)cc2)/CC)cc1	positive	training
Diflorasone	F[C@@]12[C@H]([C@H]3[C@@]([C@](O)([C@H](C3)C)C(=O)CO)(C[C@@H]1O)C)C[C@H](F)C1=CC(=O)C=C[C@]21C	negative	training
Diflunisal	Fc1c(c2cc(c(O)cc2)C(=O)O)ccc(F)c1	positive	training
Difluprednate	F[C@@]12[C@H]([C@H]3[C@@]([C@](OC(=O)CCC)(CC3)C(=O)COC(=O)C)(C[C@@H]1O)C)C[C@H](F)C1=CC(=O)C=C[C@]21C	negative	training
Digitoxin	O[C@@]12[C@H]3[C@@H]([C@@]4([C@H](CC3)C[C@@H](O[C@@H]3O[C@@H]([C@@H](O[C@@H]5O[C@@H]([C@@H](O[C@@H]6O[C@@H]([C@@H](O)[C@@H](O)C6)C)[C@@H](O)C5)C)[C@@H](O)C3)C)CC4)C)CC[C@@]1([C@H](CC2)C1=CC(=O)OC1)C	negative	training
Digoxin	O[C@@]12[C@H]3[C@@H]([C@@]4([C@H](CC3)C[C@@H](O[C@@H]3O[C@@H]([C@@H](O[C@@H]5O[C@@H]([C@@H](O[C@@H]6O[C@@H]([C@@H](O)[C@@H](O)C6)C)[C@@H](O)C5)C)[C@@H](O)C3)C)CC4)C)C[C@@H](O)[C@@]1([C@@H](CC2)C1=CC(=O)OC1)C	negative	black|NE
Dihydralazine	n1nc(NN)c2c(c1NN)cccc2	positive	training
Dihydroergotamine	O1[C@]2(O)N([C@H](C(=O)N3[C@H]2CCC3)Cc2ccccc2)C(=O)[C@@]1(NC(=O)[C@@H]1C[C@H]2[C@H](N(C1)C)Cc1c3c2cccc3[nH]c1)C	negative	training
Diltiazem	S1[C@H]([C@@H](OC(=O)C)C(=O)N(CCN(C)C)c2c1cccc2)c1ccc(OC)cc1	positive	training
Dimercaprol	S[C@@H](CS)CO	negative	training
Dinitrobenzene	O=N(=O)c1cc(N(=O)=O)ccc1	positive	training
Dinoprost	O[C@@H]1[C@@H]([C@H]([C@H](O)C1)/C=C/[C@@H](O)CCCCC)C/C=C\CCCC(=O)O	negative	training
Dinoprostone	O[C@H]1[C@@H]([C@H](C(=O)C1)C/C=C\CCCC(=O)O)/C=C/[C@@H](O)CCCCC	positive	training
Dioxane	O1CCOCC1	positive	training
Diphenhydramine	O([C@@H](c1ccccc1)c1ccccc1)CCN(C)C	negative	training
Diphenidol	O[C@@](CCCN1CCCCC1)(c1ccccc1)c1ccccc1	negative	training
Diphenyl	S(c1ccccc1)c1ccccc1	positive	training
Dipivefrin	O(C(=O)C(C)(C)C)c1c(OC(=O)C(C)(C)C)ccc([C@H](O)CNC)c1	negative	training
Dipyridamole	OCCN(c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO)CCO	negative	training
Diquat dibromide	[n+]12CC[n+]3c(c1cccc2)cccc3	positive	training
Dirithromycin	O1[C@@H]2[C@H]([C@@H](N[C@H]1COCCOC)[C@@H](C[C@@](O)([C@H](O[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C)[C@H]([C@H](O[C@@H]1O[C@H]([C@H](O)[C@](OC)(C1)C)C)[C@H](C(=O)O[C@@H]([C@]2(O)C)CC)C)C)C)C)C	positive	training
Disopyramide	O=C(N)[C@](CCN(C(C)C)C(C)C)(c1ccccc1)c1ncccc1	positive	training
Disulfiram	S(SC(=S)N(CC)CC)C(=S)N(CC)CC	positive	training
Disul-sodium	Clc1c(OCCOS(=O)(=O)O)ccc(Cl)c1	positive	training
Dobutamine	Oc1cc(CCN[C@@H](CCc2ccc(O)cc2)C)ccc1O	negative	training
Docetaxel	O1[C@H]2[C@](OC(=O)C)([C@@H]3[C@@]([C@@H](O)C2)(C(=O)[C@H](O)C2=C([C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@H]3OC(=O)c3ccccc3)C2(C)C)C)C)C1	positive	training
Docosanol	OCCCCCCCCCCCCCCCCCCCCCC	negative	external
Dofetilide	S(=O)(=O)(Nc1ccc(CCN(CCOc2ccc(NS(=O)(=O)C)cc2)C)cc1)C	negative	training
Dolasetron	O([C@H]1C[C@H]2N3[C@H](C[C@@H](C2)C(=O)C3)C1)C(=O)c1c2c([nH]c1)cccc2	positive	training
Donepezil	O=C1[C@@H](C[C@H]2CCN(CC2)Cc2ccccc2)Cc2c1cc(OC)c(OC)c2	negative	external
Dopamine	Oc1cc(CCN)ccc1O	negative	black|NE
Doripenem	S(C1=C(N2[C@@H]([C@H](C2=O)[C@H](O)C)[C@H]1C)C(=O)O)[C@H]1C[C@H](NC1)CNS(=O)(=O)N	positive	training
Dorzolamide	S1(=O)(=O)[C@@H](C[C@@H](NCC)c2c1sc(S(=O)(=O)N)c2)C	negative	training
Doxacurium	O(c1c2[C@H]([N+](CCc2cc(OC)c1OC)(CCCOC(=O)CCC(=O)OCCC[N+]1([C@@H](c2c(CC1)cc(OC)c(OC)c2OC)Cc1cc(OC)c(OC)c(OC)c1)C)C)Cc1cc(OC)c(OC)c(OC)c1)C	negative	training
Doxapram	O=C1N(C[C@H]([C@@]1(c1ccccc1)c1ccccc1)CCN1CCOCC1)CC	positive	training
Doxazosin	O1[C@@H](C(=O)N2CCN(CC2)c2nc3c(c(n2)N)cc(OC)c(OC)c3)COc2c1cccc2	positive	training
Doxepin	O1Cc2c(/C(=C\CCN(C)C)/c3c1cccc3)cccc2	positive	external
Doxercalciferol	O[C@@H]1C/C(=C/C=C\2/[C@H]3[C@@]([C@H](CC3)[C@H](C)/C=C/[C@@H](C(C)C)C)(CCC2)C)/C(=C)[C@@H](O)C1	negative	training
Doxorubicin	O([C@H]1C[C@@](O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)c(OC)ccc2)C(=O)CO)[C@@H]1O[C@H]([C@@H](O)[C@@H](N)C1)C	positive	pairs
Doxycycline	O[C@@H]1[C@@H]2[C@](O)(C(=O)C3=C(O)c4c([C@@H]([C@@H]13)C)cccc4O)C(=O)/C(=C(\O)/N)/C(=O)[C@H]2N(C)C	positive	training
Doxylamine	O([C@@](c1ccccc1)(c1ncccc1)C)CCN(C)C	negative	training
Droloxifene	O(c1ccc(/C(=C(/CC)\c2ccccc2)/c2cc(O)ccc2)cc1)CCN(C)C	positive	training
Dronabinol	O1C([C@H]2[C@H](c3c1cc(cc3O)CCCCC)C=C(CC2)C)(C)C	negative	training
Droperidol	Fc1ccc(C(=O)CCCN2CCC(=CC2)n2c3c([nH]c2=O)cccc3)cc1	negative	training
Duloxetine	s1c([C@@H](Oc2c3c(ccc2)cccc3)CCNC)ccc1	positive	external
Dutasteride	FC(F)(F)c1c(NC(=O)[C@@H]2[C@@]3([C@H]([C@H]4[C@@H]([C@@]5([C@H](NC(=O)C=C5)CC4)C)CC3)CC2)C)cc(cc1)C(F)(F)F	negative	external
Dyclonine	O=C(CCN1CCCCC1)c1ccc(OCCCC)cc1	negative	training
Dyphylline	O[C@@H](Cn1c2c(n(c(=O)n(c2=O)C)C)nc1)CO	negative	training
Ebrotidine	Brc1ccc(S(=O)(=O)N/C=N/CCSCc2nc(sc2)N=C(N)N)cc1	positive	training
Echothiophate	S(P(=O)(OCC)OCC)CC[N+](C)(C)C	negative	training
Econazole	Clc1c([C@@H](OCc2ccc(Cl)cc2)Cn2ccnc2)ccc(Cl)c1	negative	black|NE
Edatrexate	O=C(N[C@@H](CCC(=O)O)C(=O)O)c1ccc([C@@H](Cc2nc3c(nc2)nc(nc3N)N)CC)cc1	positive	training
Edetate disodium	OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O	negative	training
Edrophonium	Oc1cc([N+](CC)(C)C)ccc1	negative	black|NE
Eflornithine	FC(F)[C@@](N)(CCCN)C(=O)O	negative	training
Eletriptan	S(=O)(=O)(CCc1cc2c(C[C@@H]3N(CCC3)C)c[nH]c2cc1)c1ccccc1	negative	training
Eltrombopag	O=c1n([nH]c(c1N/N=C\1/C(=O)C(=CC=C1)c1cc(ccc1)C(=O)O)C)c1cc(c(cc1)C)C	positive	training
Emedastine	O(CCn1c(N2CCCN(CC2)C)nc2c1cccc2)CC	positive	training
Emtricitabine	S1C[C@H](O[C@H]1CO)n1cc(F)c(nc1=O)N	positive	training
Enalapril	O=C(N1[C@@H](CCC1)C(=O)O)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	positive	training
Enflurane	Cl[C@@H](F)C(F)(F)OC(F)F	positive	training
Enoxacin	Fc1c(N2CCNCC2)nc2n(CC)cc(c(=O)c2c1)C(=O)O	positive	training
Enoximone	S(c1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1)C	positive	training
Entacapone	O=C(N(CC)CC)/C(=C/c1cc(N(=O)=O)c(O)c(O)c1)/C#N	positive	training
Entecavir	O[C@@H]1[C@H](C(=C)[C@@H](n2c3[nH]c(nc(=O)c3nc2)N)C1)CO	positive	training
Epalrestat	S1/C(=C\C(=C\c2ccccc2)\C)/C(=O)N(CC(=O)O)C1=S	positive	training
Epinastine	N12[C@@H](c3c(Cc4c1cccc4)cccc3)CN=C2N	negative	training
Epinephrine	O[C@H](c1cc(O)c(O)cc1)CNC	negative	training
Epirubicin	O([C@H]1C[C@@](O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)c(OC)ccc2)C(=O)CO)[C@@H]1O[C@H]([C@H](O)[C@@H](N)C1)C	negative	pairs
Eplerenone	O1[C@@]23[C@H]([C@H]4[C@](C[C@@H]12)([C@@]1(OC(=O)CC1)CC4)C)[C@@H](CC1=CC(=O)CC[C@]31C)C(=O)OC	positive	training
Epoprostenol	O1[C@H]2[C@H]([C@H]([C@H](O)C2)/C=C/[C@@H](O)CCCCC)C/C/1=C/CCCC(=O)O	negative	training
Eprosartan	s1c(C/C(=C\c2n(c(nc2)CCCC)Cc2ccc(cc2)C(=O)O)/C(=O)O)ccc1	negative	training
Eptifibatide	S1SCCC(=O)N[C@@H](CCCCN=C(N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](C1)C(=O)N)Cc1c2c([nH]c1)cccc2)CC(=O)O	negative	training
Ergoloid mesylates	O1[C@@]2(O)N([C@@H](C(CC)(C)C)C(=O)N3[C@@H]2CCC3)C(=O)[C@@]1(NC(=O)[C@H]1C[C@@H]2[C@@H](N(C1)C)Cc1c3c2cccc3[nH]c1)C(C)C	negative	training
Ergotamine	O1[C@]2(O)N([C@H](C(=O)N3[C@H]2CCC3)Cc2ccccc2)C(=O)[C@@]1(NC(=O)[C@H]1CN([C@H]2C(=C1)c1c3c(C2)c[nH]c3ccc1)C)C	negative	training
Erlotinib	O(c1c(OCCOC)cc2ncnc(Nc3cc(ccc3)C#C)c2c1)CCOC	positive	training
Ertapenem	S(C1=C(N2[C@@H]([C@H](C2=O)[C@H](O)C)[C@H]1C)C(=O)O)[C@H]1C[C@H](NC1)C(=O)Nc1cc(ccc1)C(=O)O	positive	training
Erythrityl tetranitrate	O(N(=O)=O)[C@@H]([C@H](ON(=O)=O)CON(=O)=O)CON(=O)=O	positive	external
Erythromycin	O([C@@H]1[C@H]([C@H](O[C@@H]2O[C@H]([C@H](O)[C@](OC)(C2)C)C)[C@H](C(=O)O[C@@H]([C@@](O)([C@H](O)[C@H](C(=O)[C@@H](C[C@]1(O)C)C)C)C)CC)C)C)[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C	positive	training
Escitalopram	Fc1ccc([C@@]2(OCc3c2ccc(c3)C#N)CCCN(C)C)cc1	positive	training
Esmolol	O(C[C@@H](O)CNC(C)C)c1ccc(CCC(=O)OC)cc1	negative	training
Esomeprazole	[S@@](=O)(Cc1ncc(c(OC)c1C)C)c1[nH]c2c(n1)ccc(OC)c2	negative	pairs
Estazolam	Clc1cc2c(n3c(nnc3)CN=C2c2ccccc2)cc1	negative	training
Estradiol	O[C@@H]1[C@@]2([C@H]([C@H]3[C@H](CC2)c2c(CC3)cc(O)cc2)CC1)C	positive	training
Estramustine	ClCCN(C(=O)Oc1cc2c([C@H]3[C@@H]([C@@H]4[C@]([C@H](O)CC4)(CC3)C)CC2)cc1)CCCl	positive	training
Eszopiclone	Clc1ccc(N2[C@@H](OC(=O)N3CCN(CC3)C)c3nccnc3C2=O)nc1	negative	training
Etanidazole	O=C(NCCO)Cn1c(ncc1)N(=O)=O	positive	training
Ethacrynic acid	Clc1c(C(=O)C(=C)CC)ccc(OCC(=O)O)c1Cl	positive	external
Ethambutol	OC[C@@H](NCCN[C@@H](CC)CO)CC	positive	training
Ethanol	OCC	positive	training
Ethanolamine	OCCN	negative	pairs
Ethchlorvynol	Cl/C=C/[C@@](O)(CC)C#C	positive	training
Ethinamate	O(C1(CCCCC1)C#C)C(=O)N	negative	training
Ethionamide	S=C(N)c1cc(ncc1)CC	positive	training
Ethosuximide	O=C1NC(=O)C[C@]1(CC)C	negative	training
Ethyl bromide	BrCC	positive	training
Ethyl chloride	ClCC	positive	training
Ethylene chlorohydrin	ClCCO	positive	training
Ethylene dibromide	BrCCBr	positive	training
Ethylene dichloride	ClCCCl	positive	training
Ethylenediamine	NCCN	positive	pairs
Ethylenimine	N1CC1	positive	training
Ethylidene chloride	ClC(Cl)C	positive	external
Etidocaine	O=C(Nc1c(cccc1C)C)[C@@H](N(CCC)CC)CC	negative	training
Etidronate	P(=O)(O)(O)C(P(=O)(O)O)(O)C	negative	training
Etodolac	O1[C@@](c2[nH]c3c(c2CC1)cccc3CC)(CC)CC(=O)O	positive	training
Etomidate	O(C(=O)c1n([C@@H](c2ccccc2)C)cnc1)CC	negative	training
Etonogestrel	O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@H]4C(=CC(=O)CC4)CC3)C(=C)C2)CC1)CC)C#C	positive	training
Etoposide	O([C@H]1[C@@H]2[C@@H]([C@@H](c3c1cc1OCOc1c3)c1cc(OC)c(O)c(OC)c1)C(=O)OC2)[C@@H]1O[C@H]2[C@@H](O[C@@H](OC2)C)[C@H](O)[C@H]1O	positive	training
Etravirine	Brc1c(Oc2c(cc(cc2C)C#N)C)nc(Nc2ccc(cc2)C#N)nc1N	positive	training
Etretinate	O(c1c(c(c(c(c1)C)/C=C/C(=C/C=C/C(=C\C(=O)OCC)/C)/C)C)C)C	positive	black|NE
Evernimicin	Clc1c(c(C(=O)O[C@H]2[C@H](O[C@@H]3O[C@H]([C@H](OC)[C@@](N(=O)=O)(C3)C)C)C[C@H](O[C@H]3[C@H](O)C[C@@]4(O[C@]5([C@H](O4)[C@H](O[C@@H](O[C@H]4[C@@H](OC)[C@H](O[C@@H](O[C@H]6[C@H](O)[C@H](OC)[C@H](O[C@@H]7OC[C@@H]8O[C@@]9(O[C@H]8[C@H]7O)OC[C@@H](OC(=O)c7c(cc(O)cc7O)C)[C@@H]7OCO[C@@H]97)O[C@@H]6COC)[C@@H]4O)C)[C@H]5O)C)C)O[C@@H]3C)O[C@@H]2C)c(OC)c(Cl)c1O)C	positive	training
Exemestane	O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)[C@@]2(C(=CC(=O)C=C2)C(=C)C3)C)CC1)C	negative	training
Exisulind	S(=O)(=O)(c1ccc(/C=C\2/C(=C(c3c2ccc(F)c3)CC(=O)O)C)cc1)C	positive	training
Ezetimibe	Fc1ccc(N2[C@@H]([C@@H](CC[C@H](O)c3ccc(F)cc3)C2=O)c2ccc(O)cc2)cc1	positive	training
Famciclovir	O(CC(CCn1c2nc(ncc2nc1)N)COC(=O)C)C(=O)C	positive	training
Famotidine	S(CC/C(=N/S(=O)(=O)N)/N)Cc1nc(sc1)N=C(N)N	positive	training
Felbamate	O(CC(c1ccccc1)COC(=O)N)C(=O)N	positive	black|NE
Felodipine	Clc1c([C@H]2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OCC)cccc1Cl	negative	training
Fenbufen	O=C(c1ccc(c2ccccc2)cc1)CCC(=O)O	positive	training
Fenofibrate	Clc1ccc(C(=O)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2)cc1	positive	training
Fenoldopam	Clc1c2c([C@@H](CNCC2)c2ccc(O)cc2)cc(O)c1O	positive	training
Fenoprofen	O(c1cc([C@@H](C)C(=O)O)ccc1)c1ccccc1	positive	external
Fenretinide	O=C(Nc1ccc(O)cc1)/C=C(/C=C/C=C(/C=C/C1=C(CCCC1(C)C)C)\C)\C	positive	training
Fentanyl	O=C(N([C@H]1CCN(CC1)CCc1ccccc1)c1ccccc1)CC	negative	training
Fentiazac	Clc1ccc(c2nc(sc2CC(=O)O)c2ccccc2)cc1	positive	training
Fesoterodine	O(c1c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)cc(cc1)CO)C(=O)C(C)C	negative	training
Fialuridine	Ic1cn([C@@H]2O[C@@H]([C@@H](O)[C@@H]2F)CO)c(=O)[nH]c1=O	positive	training
Finasteride	O=C(NC(C)(C)C)[C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@H](NC(=O)C=C4)CC3)C)CC2)CC1)C	negative	training
Flavoxate	O(CCN1CCCCC1)C(=O)c1c2oc(c(c(=O)c2ccc1)C)c1ccccc1	negative	training
Flecainide	FC(F)(F)COc1c(C(=O)NC[C@H]2NCCCC2)cc(OCC(F)(F)F)cc1	negative	training
Fleroxacin	Fc1c(N2CCN(CC2)C)c(F)cc2c1n(CCF)cc(c2=O)C(=O)O	positive	training
Flomoxef	S(CC1=C(N2[C@H](OC1)[C@](OC)(NC(=O)CSC(F)F)C2=O)C(=O)O)c1n(nnn1)CCO	positive	training
Floxacillin	Clc1c(c2noc(c2C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(=O)O)(C)C)C)c(F)ccc1	positive	external
Floxuridine	Fc1cn([C@@H]2O[C@@H]([C@@H](O)C2)CO)c(=O)[nH]c1=O	positive	training
Fluconazole	Fc1c([C@](O)(Cn2ncnc2)Cn2ncnc2)ccc(F)c1	positive	training
Flucytosine	Fc1c([nH]c(=O)nc1)N	positive	training
Fludrocortisone	F[C@]12[C@H]([C@H]3[C@@]([C@](O)(CC3)C(=O)CO)(C[C@@H]2O)C)CCC2=CC(=O)CC[C@]12C	negative	training
Flumazenil	Fc1cc2c(n3c(CN(C2=O)C)c(nc3)C(=O)OCC)cc1	negative	training
Flumequine	Fc1cc2CC[C@H](n3c2c(c(=O)c(c3)C(=O)O)c1)C	positive	training
Flumethasone	F[C@@]12[C@H]([C@H]3[C@@]([C@](O)([C@@H](C3)C)C(=O)CO)(C[C@@H]1O)C)C[C@H](F)C1=CC(=O)C=C[C@]21C	negative	training
Flunarizine	Fc1ccc([C@H](N2CCN(CC2)C/C=C/c2ccccc2)c2ccc(F)cc2)cc1	negative	training
Flunisolide	F[C@H]1C[C@H]2[C@H]3[C@@]([C@@]4(OC(O[C@@H]4C3)(C)C)C(=O)CO)(C[C@H](O)[C@@H]2[C@@]2(C1=CC(=O)C=C2)C)C	negative	external
Fluocinolone	F[C@@]12[C@H]([C@H]3[C@@]([C@@]4(OC(O[C@@H]4C3)(C)C)C(=O)CO)(C[C@@H]1O)C)C[C@H](F)C1=CC(=O)C=C[C@]21C	negative	training
Fluocinonide	F[C@@]12[C@H]([C@H]3[C@@]([C@@]4(OC(O[C@@H]4C3)(C)C)C(=O)COC(=O)C)(C[C@@H]1O)C)C[C@H](F)C1=CC(=O)C=C[C@]21C	negative	training
Fluorescein	O1[C@@]2(c3c(C1=O)cccc3)c1c(Oc3c2ccc(O)c3)cc(O)cc1	negative	external
Fluoroacetic acid	FCC(=O)O	positive	pairs
Fluorometholone	F[C@@]12[C@H]([C@H]3[C@@]([C@](O)(CC3)C(=O)C)(C[C@@H]1O)C)C[C@@H](C1=CC(=O)C=C[C@]21C)C	negative	training
Fluorouracil	Fc1c(=O)[nH]c(=O)[nH]c1	positive	training
Fluoxetine	FC(F)(F)c1ccc(O[C@@H](CCNC)c2ccccc2)cc1	positive	training
Fluoxymesterone	F[C@]12[C@H]([C@H]3[C@@]([C@@](O)(CC3)C)(C[C@@H]2O)C)CCC2=CC(=O)CC[C@]12C	positive	training
Fluphenazine	S1c2c(N(CCCN3CCN(CC3)CCO)c3c1cccc3)cc(cc2)C(F)(F)F	positive	training
Flurandrenolide	F[C@H]1C[C@H]2[C@H]3[C@@]([C@@]4(OC(O[C@@H]4C3)(C)C)C(=O)CO)(C[C@H](O)[C@@H]2[C@@]2(C1=CC(=O)CC2)C)C	negative	training
Flurazepam	Clc1cc2c(N(CCN(CC)CC)C(=O)CN=C2c2c(F)cccc2)cc1	positive	training
Flurbiprofen	Fc1c(ccc([C@@H](C)C(=O)O)c1)c1ccccc1	positive	training
Flutamide	FC(F)(F)c1cc(NC(=O)C(C)C)ccc1N(=O)=O	positive	black|NE
Fluticasone	S(C(=O)[C@]1(O)[C@@]2([C@H]([C@H]3[C@](F)([C@@H](O)C2)[C@@]2(C(=CC(=O)C=C2)[C@@H](F)C3)C)C[C@H]1C)C)CF	negative	training
Fluvastatin	Fc1ccc(c2c(n(C(C)C)c3c2cccc3)/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)cc1	positive	training
Fluvoxamine	FC(F)(F)c1ccc(/C(=N/OCCN)/CCCCOC)cc1	positive	training
Folic acid	OC(=O)[C@@H](NC(=O)c1ccc(NCc2nc3c([nH]c(nc3=O)N)nc2)cc1)CCC(=O)O	negative	training
Fomepizole	[nH]1ncc(c1)C	positive	training
Fondaparinux	S(=O)(=O)(O)N[C@@H]1[C@@H](OS(=O)(=O)O)[C@H](O[C@@H]2O[C@@H]([C@@H](O[C@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NS(=O)(=O)O)COS(=O)(=O)O)[C@H](O)[C@H]2O)C(=O)O)[C@H](O[C@H]1O[C@H]1[C@H](O)[C@@H](OS(=O)(=O)O)[C@@H](O[C@H]1C(=O)O)O[C@H]1[C@H](O)[C@@H](NS(=O)(=O)O)[C@H](O[C@@H]1COS(=O)(=O)O)OC)COS(=O)(=O)O	positive	training
Formestane	O=C1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=C(O)C(=O)CC4)CC3)C)CC2)CC1)C	negative	training
Formoterol	O[C@@H](CN[C@@H](Cc1ccc(OC)cc1)C)c1cc(NC=O)c(O)cc1	negative	training
Fosamprenavir	S(=O)(=O)(N(C[C@@H](OP(=O)(O)O)[C@@H](NC(=O)O[C@H]1CCOC1)Cc1ccccc1)CC(C)C)c1ccc(N)cc1	positive	training
Fosaprepitant	P(=O)(O)(O)n1[nH]c(nc1=O)CN1[C@H]([C@H](OCC1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C)c1ccc(F)cc1	positive	training
Foscarnet	P(=O)(O)(O)C(=O)O	positive	training
Fosfomycin	P(=O)(O)(O)[C@H]1O[C@H]1C	positive	training
Fosinopril	P(=O)(O[C@@H](OC(=O)CC)C(C)C)(CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)CCCCc1ccccc1	positive	training
Fosphenytoin	P(=O)(OCN1C(=O)[C@](NC1=O)(c1ccccc1)c1ccccc1)(O)O	negative	training
Fospropofol	P(=O)(OCOc1c(C(C)C)cccc1C(C)C)(O)O	negative	training
Fotemustine	ClCCN(N=O)C(=O)N[C@H](P(=O)(OCC)OCC)C	positive	training
Frovatriptan	O=C(N)c1cc2c3C[C@H](NC)CCc3[nH]c2cc1	negative	training
Fulvestrant	[S@](=O)(CCCCCCCCC[C@H]1[C@H]2[C@H]3[C@](CC[C@@H]2c2c(C1)cc(O)cc2)([C@@H](O)CC3)C)CCCC(F)(F)C(F)(F)F	negative	training
Furazolidone	O1CCN(/N=C/c2oc(N(=O)=O)cc2)C1=O	positive	training
Furosemide	Clc1c(S(=O)(=O)N)cc(c(NCc2occc2)c1)C(=O)O	positive	training
Fusidic	O[C@H]1[C@@H]2[C@@]([C@@]3([C@@H](C1)/C(=C(\CCC=C(C)C)/C(=O)O)/[C@@H](OC(=O)C)C3)C)(CC[C@@H]1[C@@]2(CC[C@@H](O)[C@H]1C)C)C	positive	training
Gabapentin	OC(=O)CC1(CCCCC1)CN	positive	training
Gabexate	O(C(=O)CCCCCN=C(N)N)c1ccc(cc1)C(=O)OCC	positive	training
Gadodiamide	OC(=O)CN(CCN(CC(=O)NC)CC(=O)O)CCN(CC(=O)NC)CC(=O)O	negative	training
Gadofosveset	P(=O)(O[C@H]1CC[C@@](CC1)(c1ccccc1)c1ccccc1)(OC[C@H](N(CC(=O)O)CC(=O)O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)O	positive	training
Gadopentetic acid	OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	positive	training
Gadoteridol	O[C@@H](CN1CCN(CCN(CCN(CC1)CC(=O)O)CC(=O)O)CC(=O)O)C	negative	training
Gadoversetamide	OC(=O)CN(CCN(CC(=O)NCCOC)CC(=O)O)CCN(CC(=O)NCCOC)CC(=O)O	negative	training
Gadoxetate	OC(=O)CN(C[C@H](N(CC(=O)O)CC(=O)O)Cc1ccc(OCC)cc1)CCN(CC(=O)O)CC(=O)O	positive	training
Gallamine	O(CC[N+](CC)(CC)CC)c1c(OCC[N+](CC)(CC)CC)cccc1OCC[N+](CC)(CC)CC	negative	training
Gamma hydroxybutyrate	OCCCC(=O)O	negative	training
Ganciclovir	O(C(CO)CO)Cn1c2[nH]c(nc(=O)c2nc1)N	positive	training
Ganirelix	Clc1ccc(C[C@H](NC(=O)[C@H](NC(=O)C)Cc2cc3c(cc2)cccc3)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@H](C)C(=O)N)CCCCN=C(NCC)NCC)CC(C)C)CCCCN=C(NCC)NCC)Cc2ccc(O)cc2)CO)Cc2cccnc2)cc1	negative	training
Gatifloxacin	Fc1c(N2C[C@H](NCC2)C)c(OC)c2n(C3CC3)cc(c(=O)c2c1)C(=O)O	positive	training
Gefitinib	Clc1cc(Nc2ncnc3c2cc(OCCCN2CCOCC2)c(OC)c3)ccc1F	positive	training
Gemcitabine	FC1(F)[C@H](O)[C@H](O[C@H]1n1ccc(nc1=O)N)CO	positive	training
Gemfibrozil	O(CCCC(C)(C)C(=O)O)c1c(ccc(c1)C)C	positive	external
Gemifloxacin	Fc1c(N2C[C@@H](/C(=N/OC)/C2)CN)nc2n(C3CC3)cc(c(=O)c2c1)C(=O)O	positive	training
Gentamicin	O([C@@H]1[C@@H](O)[C@H](O[C@H]2O[C@@H](CC[C@H]2N)CN)[C@@H](N)C[C@H]1N)[C@H]1OC[C@](O)([C@H](NC)[C@H]1O)C	negative	training
Gentian violet	N(c1ccc(/C(=C\2/C=CC(=[N+](C)C)C=C2)/c2ccc(N(C)C)cc2)cc1)(C)C	negative	training
Gliclazide	S(=O)(=O)(NC(=O)NN1C[C@@H]2[C@@H](CCC2)C1)c1ccc(cc1)C	positive	training
Glimepiride	S(=O)(=O)(NC(=O)N[C@H]1CC[C@@H](CC1)C)c1ccc(CCNC(=O)N2CC(=C(C2=O)CC)C)cc1	positive	training
Glucagon	S(CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1[nH]cnc1)CO)CCC(=O)N)[C@H](O)C)Cc1ccccc1)[C@H](O)C)CO)CC(=O)O)Cc1ccc(O)cc1)CO)CCCCN)Cc1ccc(O)cc1)CC(C)C)CC(=O)O)CO)CCCNC(=N)N)CCCNC(=N)N)C)CCC(=O)N)CC(=O)O)Cc1ccccc1)C(C)C)CCC(=O)N)Cc1c2c([nH]c1)cccc2)CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)O)C	negative	training
Glutamine	OC(=O)[C@@H](N)CCC(=O)N	positive	external
Glutethimide	O=C1NC(=O)CC[C@@]1(CC)c1ccccc1	negative	training
Glyburide	Clc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)c(OC)cc1	positive	training
Glycopyrrolate	O([C@H]1C[N+](CC1)(C)C)C(=O)[C@@](O)(C1CCCC1)c1ccccc1	negative	training
Gonadorelin	O=C(N1[C@@H](CCC1)C(=O)NCC(=O)N)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1)Cc1c2c([nH]c1)cccc2)CO)Cc1ccc(O)cc1)CC(C)C)CCCN=C(N)N	negative	training
Goserelin	O=C(N1[C@@H](CCC1)C(=O)NNC(=O)N)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1)Cc1c2c([nH]c1)cccc2)CO)Cc1ccc(O)cc1)COC(C)(C)C)CC(C)C)CCCN=C(N)N	negative	training
Granisetron	O=C(N[C@H]1C[C@H]2N([C@@H](C1)CCC2)C)c1nn(c2c1cccc2)C	positive	external
Grepafloxacin	Fc1c(N2C[C@H](NCC2)C)cc2n(C3CC3)cc(c(=O)c2c1C)C(=O)O	positive	training
Griseofulvin	Clc1c2O[C@]3([C@@H](CC(=O)C=C3OC)C)C(=O)c2c(OC)cc1OC	positive	training
Guaifenesin	O(C[C@H](O)CO)c1c(OC)cccc1	negative	training
Guanabenz	Clc1c(c(Cl)ccc1)/C=N/N=C(N)N	positive	training
Guanadrel	O1C2(OC[C@H]1CN=C(N)N)CCCCC2	negative	training
Guanethidine	N1(CCCCCCC1)CCN=C(N)N	negative	training
Guanfacine	Clc1c(CC(=O)N=C(N)N)c(Cl)ccc1	positive	training
Gusperimus	O[C@H](NC(=O)CCCCCCN=C(N)N)C(=O)NCCCCNCCCN	negative	training
Halazepam	Clc1cc2c(N(CC(F)(F)F)C(=O)CN=C2c2ccccc2)cc1	negative	training
Halcinonide	ClCC(=O)[C@]12OC(O[C@@H]2C[C@@H]2[C@@]1(C[C@H](O)[C@@]1(F)[C@H]2CCC2=CC(=O)CC[C@]12C)C)(C)C	negative	external
Halobetasol	ClCC(=O)[C@]1(OC(=O)CC)[C@]2([C@@H]([C@H]3[C@](F)([C@H](O)C2)[C@@]2(C(=CC(=O)C=C2)[C@@H](F)C3)C)C[C@@H]1C)C	negative	training
Halofantrine	Clc1c2cc([C@@H](O)CCN(CCCC)CCCC)c3c(c2cc(Cl)c1)cc(cc3)C(F)(F)F	positive	training
Halothane	Br[C@@H](Cl)C(F)(F)F	positive	training
Heparin	S(=O)(=O)(O)N[C@H]1[C@H](OS(=O)(=O)O)[C@H](O[C@H]2O[C@@H]([C@@H](O)[C@@H](O)[C@H]2OS(=O)(=O)O)C(=O)O)[C@H](O[C@H]1O[C@H]1[C@H](O)[C@H](OS(=O)(=O)O)[C@@H](O[C@@H]1C(=O)O)O[C@H]1[C@H](O)[C@H](NC(=O)C)[C@@H](O[C@@H]1COS(=O)(=O)O)O)CO	positive	training
Heptachlor	Cl[C@@]12[C@H]3[C@@H]([C@@](Cl)(C1(Cl)Cl)C(=C2Cl)Cl)C=C[C@H]3Cl	positive	training
Hexachlorophene	Clc1c(Cc2c(O)c(Cl)cc(Cl)c2Cl)c(O)c(Cl)cc1Cl	negative	training
Hexafluorenium	[N+]([C@H]1c2c(c3c1cccc3)cccc2)(CCCCCC[N+]([C@H]1c2c(c3c1cccc3)cccc2)(C)C)(C)C	negative	external
Histamine	[nH]1c(CCN)cnc1	negative	training
Histrelin	O=C(N1[C@@H](CCC1)C(=O)NCC)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1)Cc1c2c([nH]c1)cccc2)CO)Cc1ccc(O)cc1)Cc1ncn(c1)Cc1ccccc1)CC(C)C)CCCN=C(N)N	negative	training
Homatropine	O([C@H]1C[C@@H]2N([C@@H](CC2)C1)C)C(=O)[C@H](O)c1ccccc1	negative	training
Homoharringtonine	O([C@H]1[C@H]2[C@@]3(N(CCC3)CCc3c2cc2OCOc2c3)C=C1OC)C(=O)[C@](O)(CCCC(O)(C)C)CC(=O)OC	positive	training
Hyaluronidase	o1c(CNc2ncnc3nc[nH]c23)ccc1	negative	training
Hydralazine	N(N)c1nncc2c1cccc2	positive	training
Hydrochlorothiazide	Clc1c(S(=O)(=O)N)cc2S(=O)(=O)NCNc2c1	positive	training
Hydroflumethiazide	S1(=O)(=O)NCNc2c1cc(S(=O)(=O)N)c(c2)C(F)(F)F	negative	external
Hydromorphone	O1[C@@H]2[C@]34[C@H]([C@H](N(CC3)C)Cc3c4c1c(O)cc3)CCC2=O	negative	training
Hydroquinidine	O[C@H]([C@@H]1N2C[C@@H]([C@H](C1)CC2)CC)c1c2c(ncc1)ccc(OC)c2	positive	training
Hydroxocobalamin	P(=O)(O[C@@H](CNC(=O)CC[C@@]1([C@H]([C@H]2[N-]/C/1=C(\C1=N/C(=C\C3=N/C(=C(\C4=N[C@@]2([C@]([C@@H]4CCC(=O)N)(CC(=O)N)C)C)/C)/[C@]([C@@H]3CCC(=O)N)(CC(=O)N)C)/C([C@@H]1CCC(=O)N)(C)C)/C)CC(=O)N)C)C)(O[C@H]1[C@@H](O)[C@H](O[C@@H]1CO)n1c2c(nc1)cc(c(c2)C)C)O	negative	training
Hydroxychloroquine	Clc1cc2nccc(N[C@@H](CCCN(CCO)CC)C)c2cc1	negative	training
Hydroxyurea	ONC(=O)N	positive	training
Hydroxyzine	Clc1ccc([C@H](N2CCN(CC2)CCOCCO)c2ccccc2)cc1	negative	training
Ibandronate	P(=O)(O)(O)C(P(=O)(O)O)(O)CCN(CCCCC)C	positive	training
Ibufenac	OC(=O)Cc1ccc(CC(C)C)cc1	positive	training
Ibuprofen	OC(=O)[C@@H](c1ccc(CC(C)C)cc1)C	positive	external
Ibutilide	S(=O)(=O)(Nc1ccc([C@@H](O)CCCN(CCCCCCC)CC)cc1)C	negative	external
Idarubicin	O([C@H]1C[C@@](O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2)C(=O)C)[C@@H]1O[C@H]([C@@H](O)[C@@H](N)C1)C	positive	training
Idoxuridine	Ic1cn([C@@H]2O[C@@H]([C@@H](O)C2)CO)c(=O)[nH]c1=O	positive	training
Ifosfamide	ClCCN1P(=O)(OCCC1)NCCCl	positive	training
Iloprost	O[C@H]1[C@@H]([C@@H]2[C@H](C1)C/C(=C\CCCC(=O)O)/C2)/C=C/[C@@H](O)[C@@H](CC#CC)C	positive	training
Imatinib	O=C(Nc1cc(Nc2nc(c3cccnc3)ccn2)c(cc1)C)c1ccc(CN2CCN(CC2)C)cc1	positive	training
Imidapril	O=C(N1[C@@H](CN(C1=O)C)C(=O)O)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	positive	training
Imipramine	N1(CCCN(C)C)c2c(CCc3c1cccc3)cccc2	positive	training
Imiquimod	n1(CC(C)C)c2c3c(nc(N)c2nc1)cccc3	positive	training
Inamrinone	O=c1[nH]cc(c2ccncc2)cc1N	positive	training
Indene	c12CC=Cc1cccc2	positive	training
Indinavir	O[C@H](CN1[C@@H](CN(CC1)Cc1cccnc1)C(=O)NC(C)(C)C)C[C@@H](C(=O)N[C@@H]1[C@H](O)Cc2c1cccc2)Cc1ccccc1	positive	training
Indocyanine green	S(=O)(=O)(O)CCCC[N+]1=C(C(c2c1ccc1c2cccc1)(C)C)/C=C/C=C/C=C/C=C/1\N(c2c(C1(C)C)c1c(cc2)cccc1)CCCCS(=O)(=O)O	negative	training
Indomethacin	Clc1ccc(C(=O)n2c3c(c(c2C)CC(=O)O)cc(OC)cc3)cc1	positive	training
Iobenguane i 131	[131I]c1cc(CN=C(N)N)ccc1	positive	training
Iobitridol	Ic1c(C(=O)N(C[C@H](O)CO)C)c(I)c(NC(=O)C(CO)CO)c(I)c1C(=O)N(C[C@H](O)CO)C	negative	training
Iocetamic acid	Ic1c(N(C[C@@H](C)C(=O)O)C(=O)C)c(I)cc(I)c1N	negative	training
Iodamide	Ic1c(CNC(=O)C)c(I)c(c(I)c1NC(=O)C)C(=O)O	negative	external
Iodipamide	Ic1c(NC(=O)CCCCC(=O)Nc2c(I)c(c(I)cc2I)C(=O)O)c(I)cc(I)c1C(=O)O	positive	training
Iodixanol	Ic1c(N(C[C@H](O)CN(c2c(I)c(c(I)c(c2I)C(=O)NC[C@H](O)CO)C(=O)NC[C@H](O)CO)C(=O)C)C(=O)C)c(I)c(c(I)c1C(=O)NC[C@H](O)CO)C(=O)NC[C@H](O)CO	negative	training
Iodoform	IC(I)I	positive	external
Iohexol	Ic1c(N(C[C@H](O)CO)C(=O)C)c(I)c(c(I)c1C(=O)NC[C@H](O)CO)C(=O)NC[C@H](O)CO	negative	training
Iopamidol	Ic1c(c(I)c(NC(=O)[C@@H](O)C)c(I)c1C(=O)NC(CO)CO)C(=O)NC(CO)CO	negative	training
Iopanoic acid	Ic1c(C[C@@H](CC)C(=O)O)c(I)cc(I)c1N	negative	training
Iophendylate	Ic1c([C@H](CCCCCCCCC(=O)OCC)C)cccc1	negative	external
Iotrolan	Ic1c(C(=O)N[C@@H]([C@H](O)CO)CO)c(I)c(N(C(=O)CC(=O)N(c2c(I)c(C(=O)N[C@@H]([C@H](O)CO)CO)c(I)c(C(=O)N[C@@H]([C@H](O)CO)CO)c2I)C)C)c(I)c1C(=O)N[C@@H]([C@H](O)CO)CO	negative	training
Ioversol	Ic1c(N(CCO)C(=O)CO)c(I)c(c(I)c1C(=O)NC[C@H](O)CO)C(=O)NC[C@H](O)CO	negative	training
Ioxilan	Ic1c(N(C[C@H](O)CO)C(=O)C)c(I)c(c(I)c1C(=O)NC[C@H](O)CO)C(=O)NCCO	negative	training
Ipodate	Ic1c(CCC(=O)O)c(I)cc(I)c1/N=C/N(C)C	negative	training
Iproniazid	O=C(NNC(C)C)c1ccncc1	positive	black|NE
Irbesartan	O=C1N(C(=NC21CCCC2)CCCC)Cc1ccc(cc1)c1c(cccc1)c1n[nH]nn1	positive	training
Irinotecan	O(C(=O)N1CC[C@H](N2CCCCC2)CC1)c1cc2c(c3Cn4c(c3nc2cc1)cc1[C@@](O)(CC)C(=O)OCc1c4=O)CC	positive	training
Isepamicin	O([C@H]1[C@H](NC(=O)[C@@H](O)CN)C[C@H](N)[C@@H](O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CN)[C@@H]1O)[C@H]1OC[C@](O)([C@H](NC)[C@H]1O)C	positive	training
Isocarboxazid	o1nc(C(=O)NNCc2ccccc2)cc1C	positive	training
Isoetharine	O[C@@H]([C@H](NC(C)C)CC)c1cc(O)c(O)cc1	negative	training
Isoflurane	Cl[C@@H](OC(F)F)C(F)(F)F	positive	training
Isoflurophate	P(=O)(F)(OC(C)C)OC(C)C	negative	training
Isoniazid	O=C(NN)c1ccncc1	positive	black|NE
Isopropamide	O=C(N)[C@](CC[N+](C(C)C)(C(C)C)C)(c1ccccc1)c1ccccc1	negative	external
Isoproterenol	O[C@@H](CNC(C)C)c1cc(O)c(O)cc1	negative	black|NE
Isosorbide dinitrate	O1[C@H]2[C@H](OC[C@H]2ON(=O)=O)[C@@H](ON(=O)=O)C1	negative	training
Isotretinoin	OC(=O)/C=C(\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C)/C	positive	training
Isradipine	O(C(=O)C1=C(NC(=C([C@H]1c1c2nonc2ccc1)C(=O)OC)C)C)C(C)C	positive	training
Itraconazole	Clc1c([C@@]2(O[C@H](CO2)COc2ccc(N3CCN(CC3)c3ccc(n4c(=O)n(nc4)[C@@H](CC)C)cc3)cc2)Cn2ncnc2)ccc(Cl)c1	positive	training
Ivermectin	O1[C@]2(O[C@H]3C[C@H](OC(=O)[C@H]4[C@@]5(O)[C@H](OC/C/5=C\C=C\[C@@H]([C@H](O[C@@H]5O[C@H]([C@H](O[C@@H]6O[C@H]([C@H](O)[C@@H](OC)C6)C)[C@@H](OC)C5)C)/C(=C/C3)/C)C)[C@H](O)C(=C4)C)C2)CC[C@@H]([C@H]1[C@H](CC)C)C	positive	training
Ixabepilone	s1cc(nc1C)/C=C(/[C@H]1NC(=O)C[C@H](O)C(C(=O)[C@@H]([C@@H](O)[C@H](CCC[C@]2(O[C@H]2C1)C)C)C)(C)C)\C	negative	training
Josamycin	O([C@H]1[C@H](N(C)C)[C@@H](O)[C@@H](O[C@@H]1C)O[C@H]1[C@H](C[C@H]([C@@H](O)/C=C/C=C/C[C@H](OC(=O)C[C@@H](OC(=O)C)[C@@H]1OC)C)C)CC=O)[C@@H]1O[C@H]([C@H](OC(=O)CC(C)C)[C@](O)(C1)C)C	positive	training
Kanamycin	O([C@@H]1[C@@H](O)[C@H](O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CN)[C@@H](N)C[C@H]1N)[C@H]1O[C@@H]([C@@H](O)[C@H](N)[C@H]1O)CO	negative	training
Ketamine	Clc1c([C@]2(NC)CCCCC2=O)cccc1	negative	training
Ketoconazole	Clc1c([C@@]2(O[C@H](CO2)COc2ccc(N3CCN(CC3)C(=O)C)cc2)Cn2ccnc2)ccc(Cl)c1	positive	black|NE
Ketoprofen	OC(=O)[C@@H](c1cc(ccc1)C(=O)c1ccccc1)C	positive	training
Ketorolac	OC(=O)[C@H]1CCn2c1ccc2C(=O)c1ccccc1	positive	training
Ketotifen	s1c2c(C(=C3CCN(CC3)C)c3c(CC2=O)cccc3)cc1	negative	training
Labetalol	O[C@@H](CN[C@@H](CCc1ccccc1)C)c1cc(c(O)cc1)C(=O)N	positive	training
Lacidipine	O(C(=O)C1=C(NC(=C([C@H]1c1c(cccc1)/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C)CC	positive	training
Lacosamide	O(C[C@@H](NC(=O)C)C(=O)NCc1ccccc1)C	negative	external
Lactulose	O([C@H]1[C@H](O)[C@@](O[C@@H]1CO)(O)CO)[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)CO	negative	external
Lamivudine	S1C[C@H](O[C@H]1CO)n1ccc(nc1=O)N	positive	training
Lanreotide	S1SC[C@@H](NC(=O)[C@H](N)Cc2cc3c(cc2)cccc3)C(=O)N[C@@H](C(=O)N[C@@H](Cc2c3c([nH]c2)cccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C1)C(=O)N[C@@H]([C@H](O)C)C(=O)N)Cc1ccc(O)cc1	negative	training
Lapatinib	Clc1cc(Nc2ncnc3c2cc(c2oc(CNCCS(=O)(=O)C)cc2)cc3)ccc1OCc1cc(F)ccc1	positive	training
Latanoprost	O[C@H]1[C@@H]([C@H]([C@@H](O)C1)C/C=C\CCCC(=O)OC(C)C)CC[C@@H](O)CCc1ccccc1	negative	training
Lazabemide	Clc1ccc(nc1)C(=O)NCCN	positive	training
Leflunomide	FC(F)(F)c1ccc(NC(=O)c2c(onc2)C)cc1	positive	training
Lenalidomide	O=C1N([C@H]2CCC(=O)NC2=O)Cc2c1cccc2N	positive	training
Letrozole	n1(ncnc1)[C@@H](c1ccc(cc1)C#N)c1ccc(cc1)C#N	positive	external
Leucovorin	O=c1nc([nH]c2NC[C@H](N(c12)C=O)CNc1ccc(cc1)C(=O)N[C@H](CCC(=O)O)C(=O)O)N	negative	training
Leuprolide	O=C(N1[C@@H](CCC1)C(=O)NCC)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1)Cc1c2c([nH]c1)cccc2)CO)Cc1ccc(O)cc1)C(C)C)C(C)C)CCCN=C(N)N	positive	training
Levamisole	S1C2=N[C@H](CN2CC1)c1ccccc1	positive	training
Levetiracetam	O=C1N(CCC1)[C@@H](CC)C(=O)N	positive	training
Levobunolol	O(c1c2CCCC(=O)c2ccc1)C[C@@H](O)CNC(C)(C)C	negative	external
Levocabastine	Fc1ccc([C@]2(CC[C@H](N3C[C@H]([C@](CC3)(c3ccccc3)C(=O)O)C)CC2)C#N)cc1	negative	training
Levocarnitine	O[C@@H](C[N+](C)(C)C)CC(=O)O	negative	external
Levocetirizine	Clc1ccc([C@@H](N2CCN(CC2)CCOCC(=O)O)c2ccccc2)cc1	positive	training
Levofloxacin	Fc1c(N2CCN(CC2)C)c2OC[C@@H](n3c2c(c1)c(=O)c(c3)C(=O)O)C	positive	training
Levoleucovorin	O=c1nc([nH]c2NC[C@@H](N(c12)C=O)CNc1ccc(cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N	negative	training
Levonorgestrel	O[C@@]1([C@@]2([C@H]([C@H]3[C@H](CC2)[C@@H]2C(=CC(=O)CC2)CC3)CC1)CC)C#C	positive	training
Levorphanol	Oc1cc2[C@]34[C@H]([C@@H](N(CC3)C)Cc2cc1)CCCC4	negative	training
Liarozole	Clc1cc([C@@H](n2ccnc2)c2cc3[nH]cnc3cc2)ccc1	positive	training
Lidocaine	O=C(Nc1c(cccc1C)C)CN(CC)CC	negative	black|NE
Lindane	Cl[C@H]1[C@H](Cl)[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@H]1Cl	negative	training
Linezolid	Fc1c(N2CCOCC2)ccc(N2C[C@@H](OC2=O)CNC(=O)C)c1	positive	training
Liothyronine	Ic1cc(C[C@H](N)C(=O)O)cc(I)c1Oc1cc(I)c(O)cc1	negative	training
Lisdexamfetamine	O=C(N[C@H](Cc1ccccc1)C)[C@@H](N)CCCCN	negative	training
Lisinopril	O=C(N1[C@@H](CCC1)C(=O)O)[C@@H](N[C@@H](CCc1ccccc1)C(=O)O)CCCCN	positive	training
Lodoxamide	Clc1c(NC(=O)C(=O)O)cc(cc1NC(=O)C(=O)O)C#N	negative	training
Lofepramine	Clc1ccc(C(=O)CN(CCCN2c3c(CCc4c2cccc4)cccc3)C)cc1	positive	training
Lomefloxacin	Fc1c(N2C[C@H](NCC2)C)c(F)cc2c1n(CC)cc(c2=O)C(=O)O	negative	training
Lomustine	ClCCN(N=O)C(=O)NC1CCCCC1	negative	training
Lonidamine	Clc1c(Cn2nc(c3c2cccc3)C(=O)O)ccc(Cl)c1	positive	training
Loperamide	Clc1ccc([C@]2(O)CCN(CC2)CC[C@@](c2ccccc2)(c2ccccc2)C(=O)N(C)C)cc1	negative	training
Loracarbef	ClC1=C(N2[C@@H]([C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)CC1)C(=O)O	positive	training
Lorazepam	Clc1cc2C(=N[C@H](O)C(=O)Nc2cc1)c1c(Cl)cccc1	positive	training
Losartan	Clc1nc(n(Cc2ccc(cc2)c2c(cccc2)c2n[nH]nn2)c1CO)CCCC	positive	training
Loteprednol	ClCOC(=O)[C@]1(O)[C@@]2([C@H]([C@H]3[C@H]([C@@H](O)C2)[C@@]2(C(=CC(=O)C=C2)CC3)C)CC1)C	negative	training
Lovastatin	O([C@@H]1[C@@H]2[C@H]([C@H](C=CC2=C[C@@H](C1)C)C)CC[C@H]1OC(=O)C[C@H](O)C1)C(=O)[C@H](CC)C	positive	training
Loxapine	Clc1cc2C(=Nc3c(Oc2cc1)cccc3)N1CCN(CC1)C	positive	training
Lubiprostone	FC(F)([C@@]1(O[C@H]2[C@@H]([C@H](C(=O)C2)CCCCCCC(=O)O)CC1)O)CCCC	negative	training
Lumiracoxib	Clc1c(Nc2c(cc(cc2)C)CC(=O)O)c(F)ccc1	positive	external
Lypressin	S1SC[C@H](N)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)Cc1ccccc1)Cc1ccc(O)cc1	negative	training
Mafenide	S(=O)(=O)(N)c1ccc(cc1)CN	negative	training
Malathion	S(P(=S)(OC)OC)[C@@H](CC(=O)OCC)C(=O)OCC	negative	external
Mangafodipir	P(=O)(OCc1c(CN(CCN(Cc2c(COP(=O)(O)O)cnc(c2O)C)CC(=O)O)CC(=O)O)c(O)c(nc1)C)(O)O	positive	training
Mannitol	O[C@@H]([C@H](O)[C@H](O)CO)[C@H](O)CO	negative	training
Maraviroc	FC1(F)CCC(C(=O)N[C@@H](CCN2[C@H]3C[C@H](n4c(nnc4C)C(C)C)C[C@@H]2CC3)c2ccccc2)CC1	positive	training
Marimastat	O[C@@H]([C@@H](CC(C)C)C(=O)N[C@@H](C(C)(C)C)C(=O)NC)C(=O)NO	positive	training
Mazindol	Clc1ccc([C@]2(O)N3C(=NCC3)c3c2cccc3)cc1	negative	training
Mebendazole	O=C(c1cc2[nH]c(nc2cc1)NC(=O)OC)c1ccccc1	positive	training
Mecamylamine	N([C@]1(C([C@H]2C[C@@H]1CC2)(C)C)C)C	negative	training
Mechlorethamine	ClCCC(N)CCCl	negative	training
Meclizine	Clc1ccc([C@H](N2CCN(CC2)Cc2cc(ccc2)C)c2ccccc2)cc1	negative	training
Meclofenamate	Clc1c(Nc2c(cccc2)C(=O)O)c(Cl)ccc1C	positive	training
Medroxyprogesterone	O[C@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=CC(=O)CC4)[C@H](C3)C)C)CC2)CC1)C)C(=O)C	positive	training
Medrysone	O[C@@H]1[C@H]2[C@H]([C@H]3[C@](C1)([C@H](CC3)C(=O)C)C)C[C@@H](C1=CC(=O)CC[C@]21C)C	negative	training
Mefenamic acid	OC(=O)c1c(Nc2c(c(ccc2)C)C)cccc1	positive	training
Mefloquine	FC(F)(F)c1nc2c(c([C@H](O)[C@@H]3NCCCC3)c1)cccc2C(F)(F)F	positive	training
Meloxicam	S1(=O)(=O)N(/C(=C(/O)\Nc2sc(cn2)C)/C(=O)c2c1cccc2)C	positive	training
Melphalan	ClCCN(c1ccc(C[C@H](N)C(=O)O)cc1)CCCl	positive	training
Memantine	N[C@]12C[C@@]3(C[C@](C1)(C[C@@H](C3)C2)C)C	positive	training
Mepenzolate	O([C@H]1C[N+](CCC1)(C)C)C(=O)[C@](O)(c1ccccc1)c1ccccc1	negative	training
Meperidine	O(C(=O)C1(CCN(CC1)C)c1ccccc1)CC	negative	training
Mephentermine	N(C(Cc1ccccc1)(C)C)C	negative	training
Mephobarbital	O=C1N(C(=O)NC(=O)[C@]1(CC)c1ccccc1)C	positive	training
Mepivacaine	O=C(Nc1c(cccc1C)C)[C@H]1N(CCCC1)C	negative	training
Meprobamate	O(CC(CCC)(COC(=O)N)C)C(=O)N	negative	training
Mercaptopurine	S=c1nc[nH]c2nc[nH]c12	positive	training
Meropenem	S(C1=C(N2[C@@H]([C@H](C2=O)[C@H](O)C)[C@H]1C)C(=O)O)[C@H]1C[C@H](NC1)C(=O)N(C)C	positive	training
Mesalamine	Oc1c(cc(N)cc1)C(=O)O	positive	training
Mesna	S(=O)(=O)(O)CCS	negative	training
Mesoridazine	S1c2c(N(CC[C@H]3N(CCCC3)C)c3c1cccc3)cc([S@](=O)C)cc2	negative	training
Metaproterenol	O[C@@H](CNC(C)C)c1cc(O)cc(O)c1	negative	training
Metaraminol	O[C@@H]([C@@H](N)C)c1cc(O)ccc1	negative	training
Metergoline	O(C(=O)NC[C@@H]1C[C@H]2[C@H](N(C1)C)Cc1c3c2cccc3n(c1)C)Cc1ccccc1	positive	training
Metformin	N(C)(C)C(=N)N=C(N)N	positive	training
Methacholine	O([C@@H](C[N+](C)(C)C)C)C(=O)C	negative	training
Methadone	O=C([C@](C[C@H](N(C)C)C)(c1ccccc1)c1ccccc1)CC	positive	training
Methamphetamine	N([C@H](Cc1ccccc1)C)C	negative	training
Methantheline	O(CC[N+](CC)(CC)C)C(=O)[C@H]1c2c(Oc3c1cccc3)cccc2	negative	training
Methazolamide	S(=O)(=O)(N)c1s/c(=N\C(=O)C)/n(n1)C	negative	training
Methdilazine	S1c2c(N(C[C@H]3CCN(C3)C)c3c1cccc3)cccc2	positive	training
Methenamine	N12CN3CN(C1)CN(C2)C3	positive	training
Methenolone	O([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)CC(=O)C=C4C)C)CC2)CC1)C)C(=O)C	positive	training
Methicillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)c1c(OC)cccc1OC	negative	training
Methimazole	S=c1n(cc[nH]1)C	positive	training
Methocarbamol	O(C[C@H](O)COC(=O)N)c1c(OC)cccc1	negative	training
Methohexital	O=C1N(C(=O)NC(=O)[C@]1([C@@H](C)C#CCC)CC=C)C	positive	training
Methomyl	S(/C(=N/OC(=O)NC)/C)C	positive	training
Methotrexate	OC(=O)[C@@H](NC(=O)c1ccc(N(Cc2nc3c(nc2)nc(nc3N)N)C)cc1)CCC(=O)O	positive	training
Methotrimeprazine	S1c2c(N(C[C@@H](CN(C)C)C)c3c1cccc3)cc(OC)cc2	negative	training
Methoxamine	O[C@@H]([C@H](N)C)c1c(OC)ccc(OC)c1	negative	black|NE
Methoxsalen	o1c2c(cc3c(oc(=O)cc3)c2OC)cc1	positive	training
Methoxychlor	ClC(Cl)(Cl)[C@@H](c1ccc(OC)cc1)c1ccc(OC)cc1	positive	training
Methoxyflurane	ClC(Cl)C(F)(F)OC	positive	training
Methscopolamine	O1[C@@H]2[C@H]3[N+]([C@@H]([C@H]12)C[C@@H](OC(=O)[C@@H](CO)c1ccccc1)C3)(C)C	negative	external
Methsuximide	O=C1N(C(=O)C[C@@]1(c1ccccc1)C)C	negative	training
Methyclothiazide	ClC[C@H]1N(S(=O)(=O)c2c(N1)cc(Cl)c(S(=O)(=O)N)c2)C	negative	external
Methyl chloride	ClC	positive	training
Methylaniline	N(c1ccccc1)C	positive	training
Methyldopa	OC(=O)[C@](N)(Cc1cc(O)c(O)cc1)C	positive	training
Methylergonovine	O=C(N[C@@H](CC)CO)[C@H]1CN([C@H]2C(=C1)c1c3c(C2)c[nH]c3ccc1)C	negative	training
Methylnaltrexone	O[C@@]12[C@]34CC[N+]([C@@H]1Cc1c4c(O[C@H]3C(=O)CC2)c(O)cc1)(CC1CC1)C	negative	training
Methylphenidate	O(C(=O)[C@@H]([C@H]1NCCCC1)c1ccccc1)C	positive	pairs
Methylprednisolone	O[C@]1([C@@]2([C@H]([C@H]3[C@H]([C@@H](O)C2)[C@@]2(C(=CC(=O)C=C2)[C@H](C3)C)C)CC1)C)C(=O)CO	positive	training
Methyltestosterone	O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C)C	positive	training
Methysergide	O=C(N[C@@H](CC)CO)[C@H]1CN([C@H]2C(=C1)c1c3c(C2)cn(c3ccc1)C)C	negative	black|NE
Metipranolol	O(C[C@@H](O)CNC(C)C)c1c(c(c(OC(=O)C)c(c1)C)C)C	negative	training
Metoclopramide	Clc1cc(C(=O)NCCN(CC)CC)c(OC)cc1N	negative	external
Metocurine	O1c2c3[C@H]([N+](CCc3cc(OC)c2OC)(C)C)Cc2cc(Oc3cc4[C@@H]([N+](CCc4cc3OC)(C)C)Cc3ccc1cc3)c(OC)cc2	negative	training
Metolazone	Clc1cc2N[C@H](N(C(=O)c2cc1S(=O)(=O)N)c1c(cccc1)C)C	positive	training
Metoprolol	O(C[C@@H](O)CNC(C)C)c1ccc(CCOC)cc1	positive	training
Metribuzin	S(c1n(N)c(=O)c(nn1)C(C)(C)C)C	positive	training
Metrizamide	Ic1c(C(=O)N[C@@H]2[C@@H](O)[C@H](O)[C@H](O[C@H]2O)CO)c(I)c(NC(=O)C)c(I)c1N(C)C(=O)C	negative	training
Metronidazole	OCCn1c(ncc1N(=O)=O)C	positive	training
Metyrapone	O=C(C(c1cccnc1)(C)C)c1cccnc1	negative	training
Metyrosine	OC(=O)[C@@](N)(Cc1ccc(O)cc1)C	negative	training
Mexiletine	O(C[C@H](N)C)c1c(cccc1C)C	positive	training
Mezlocillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(S(=O)(=O)C)C1=O)c1ccccc1	positive	training
Mibefradil	Fc1cc2c([C@@H]([C@](OC(=O)COC)(CC2)CCN(CCCc2[nH]c3c(n2)cccc3)C)C(C)C)cc1	negative	external
Micafungin	S(=O)(=O)(Oc1cc([C@@H](O)[C@@H](O)[C@H]2NC(=O)[C@H]3N(C[C@@H](O)C3)C(=O)[C@H](NC(=O)[C@@H](NC(=O)c3ccc(cc3)c3noc(c3)c3ccc(OCCCCC)cc3)C[C@@H](O)[C@@H](O)NC(=O)[C@H]3N(C[C@H]([C@@H]3O)C)C(=O)[C@H](NC2=O)[C@H](O)CC(=O)N)[C@H](O)C)ccc1O)O	positive	training
Miconazole	Clc1c([C@@H](OCc2c(Cl)cc(Cl)cc2)Cn2ccnc2)ccc(Cl)c1	negative	black|NE
Midazolam	Clc1cc2c(n3c(CN=C2c2c(F)cccc2)cnc3C)cc1	negative	training
Midodrine	O[C@@H](c1c(OC)ccc(OC)c1)CNC(=O)CN	negative	training
Mifepristone	O[C@@]1([C@@]2([C@H]([C@H]3C(=C4C(=CC(=O)CC4)CC3)[C@H](C2)c2ccc(N(C)C)cc2)CC1)C)C#CC	negative	training
Miglitol	O[C@@H]1[C@H](N(C[C@H](O)[C@H]1O)CCO)CO	negative	training
Miglustat	O[C@@H]1[C@H](N(C[C@H](O)[C@H]1O)CCCC)CO	negative	training
Milrinone	O=c1[nH]c(c(c2ccncc2)cc1C#N)C	positive	training
Miltefosine	P(=O)(OCC[N+](C)(C)C)(OCCCCCCCCCCCCCCCC)O	positive	training
Minocycline	O[C@@]12[C@@H](C[C@H]3C(=C(O)c4c(C3)c(N(C)C)ccc4O)C1=O)[C@H](N(C)C)C(=O)/C(=C(/O)\N)/C2=O	positive	training
Minoxidil	On1c(N)cc(N2CCCCC2)nc1=N	positive	training
Miokamycin	O([C@H]1[C@H](N(C)C)[C@@H](O)[C@@H](O[C@@H]1C)O[C@H]1[C@H](C[C@H]([C@@H](OC(=O)C)/C=C/C=C/C[C@H](OC(=O)C[C@@H](OC(=O)CC)[C@@H]1OC)C)C)CC=O)[C@@H]1O[C@H]([C@H](OC(=O)CC)[C@](OC(=O)C)(C1)C)C	negative	training
Mirtazapine	N12[C@@H](CN(CC1)C)c1c(Cc3c2nccc3)cccc1	positive	training
Mitoguazone	N(=C(\C)/C=N/N=C(N)N)\N=C(N)N	positive	training
Mitolactol	BrC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CBr	positive	training
Mitomycin	O([C@@]12N(C[C@@H]3N[C@H]13)C1=C([C@H]2COC(=O)N)C(=O)C(=C(C1=O)C)N)C	positive	training
Mitotane	ClC(Cl)[C@@H](c1ccc(Cl)cc1)c1c(Cl)cccc1	negative	training
Mitoxantrone	O=C1c2c(c(NCCNCCO)ccc2NCCNCCO)C(=O)c2c1c(O)ccc2O	positive	training
Mivacurium	O(CCC[N+]1([C@@H](c2c(CC1)cc(OC)c(OC)c2)Cc1cc(OC)c(OC)c(OC)c1)C)C(=O)CC/C=C/CCC(=O)OCCC[N+]1([C@@H](c2c(CC1)cc(OC)c(OC)c2)Cc1cc(OC)c(OC)c(OC)c1)C	negative	training
M-nitroaniline	O=N(=O)c1cc(N)ccc1	positive	training
Modafinil	[S@](=O)([C@@H](c1ccccc1)c1ccccc1)CC(=O)N	positive	training
Moexipril	O=C(N1[C@@H](Cc2c(C1)cc(OC)c(OC)c2)C(=O)O)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	positive	training
Molindone	O1CCN(C[C@@H]2CCc3[nH]c(c(c3C2=O)CC)C)CC1	positive	training
Mometasone	Cl[C@@]12[C@H]([C@H]3[C@@]([C@](O)([C@@H](C3)C)C(=O)CCl)(C[C@@H]1O)C)CCC1=CC(=O)C=C[C@]21C	negative	training
Monobenzone	O(Cc1ccccc1)c1ccc(O)cc1	negative	training
Monoctanoin	O(C(=O)CCCCCCC)C[C@H](O)CO	positive	training
Montelukast	Clc1cc2nc(/C=C/c3cc([C@H](SCC4(CC4)CC(=O)O)CCc4c(C(O)(C)C)cccc4)ccc3)ccc2cc1	positive	training
Moricizine	S1c2c(N(C(=O)CCN3CCOCC3)c3c1cccc3)cc(NC(=O)OCC)cc2	positive	training
Morniflumate	FC(F)(F)c1cc(Nc2ncccc2C(=O)OCCN2CCOCC2)ccc1	negative	training
Morphine	O1[C@@H]2[C@]34[C@H]([C@H](N(CC3)C)Cc3c4c1c(O)cc3)C=C[C@@H]2O	positive	training
Moxalactam	S(CC1=C(N2[C@H](OC1)[C@](OC)(NC(=O)[C@@H](c1ccc(O)cc1)C(=O)O)C2=O)C(=O)O)c1n(nnn1)C	positive	external
Moxifloxacin	Fc1c(N2C[C@H]3[C@H](NCCC3)C2)c(OC)c2n(C3CC3)cc(c(=O)c2c1)C(=O)O	positive	training
Moxisylyte	O(c1c(C(C)C)cc(OC(=O)C)c(c1)C)CCN(C)C	positive	training
Mupirocin	O1[C@H]([C@@H]1[C@H]([C@@H](O)C)C)C[C@@H]1[C@@H](O)[C@@H](O)[C@@H](OC1)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C	negative	training
Mycophenolic acid	O1Cc2c(c(O)c(c(OC)c2C)C/C=C(/CCC(=O)O)\C)C1=O	positive	training
"N,n-dimethylacetamide"	C(=O)(C)N(C)C	positive	training
"N,n-dimethylformamide"	C(=O)N(C)C	positive	training
N-2-fluorenylacetamide	O=C(Nc1cc2Cc3c(c2cc1)cccc3)C	positive	training
Nabilone	O1C([C@H]2[C@@H](CC(=O)CC2)c2c1cc(C(CCCCCC)(C)C)cc2O)(C)C	negative	training
Nadolol	O[C@@H]1[C@H](O)Cc2c(C1)c(OC[C@@H](O)CNC(C)(C)C)ccc2	negative	training
Nafarelin	O=C(N1[C@@H](CCC1)C(=O)NCC(=O)N)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1)Cc1c2c([nH]c1)cccc2)CO)Cc1ccc(O)cc1)Cc1cc2c(cc1)cccc2)CC(C)C)CCCN=C(N)N	negative	training
Nafcillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)c1c2c(ccc1OCC)cccc2	positive	training
Naftifine	N(Cc1c2c(ccc1)cccc2)(C/C=C/c1ccccc1)C	negative	training
Nalbuphine	O1[C@@H]2[C@]34[C@](O)([C@H](N(CC3)CC3CCC3)Cc3c4c1c(O)cc3)CC[C@@H]2O	negative	training
Nalidixic acid	O=c1c2c(n(CC)cc1C(=O)O)nc(cc2)C	negative	training
Naloxone	O1[C@@H]2[C@]34[C@](O)([C@H](N(CC3)CC=C)Cc3c4c1c(O)cc3)CCC2=O	negative	training
Naltrexone	O1[C@@H]2[C@]34[C@](O)([C@H](N(CC3)CC3CC3)Cc3c4c1c(O)cc3)CCC2=O	positive	black|NE
Nandrolone	O[C@@H]1[C@@]2([C@H]([C@H]3[C@H](CC2)[C@@H]2C(=CC(=O)CC2)CC3)CC1)C	positive	training
Naphazoline	N1C(=NCC1)Cc1c2c(ccc1)cccc2	negative	external
Naproxen	O(c1cc2c(cc([C@H](C)C(=O)O)cc2)cc1)C	positive	training
Naratriptan	S(=O)(=O)(NC)CCc1cc2c(C3CCN(CC3)C)c[nH]c2cc1	negative	external
Nateglinide	O=C(N[C@H](Cc1ccccc1)C(=O)O)[C@H]1CC[C@@H](CC1)C(C)C	positive	training
Nebivolol	Fc1cc2CC[C@@H](Oc2cc1)[C@H](O)CNC[C@@H](O)[C@@H]1Oc2c(CC1)cc(F)cc2	positive	training
Nedocromil	o1c2c(c3n(CC)c(cc(=O)c3cc2c(=O)cc1C(=O)O)C(=O)O)CCC	negative	training
Nefazodone	Clc1cc(N2CCN(CC2)CCCn2nc(n(c2=O)CCOc2ccccc2)CC)ccc1	positive	black|NE
Nelarabine	O1[C@@H](n2c3nc(nc(OC)c3nc2)N)[C@@H](O)[C@H](O)[C@H]1CO	negative	training
Nelfinavir	S(C[C@H](NC(=O)c1c(c(O)ccc1)C)[C@H](O)CN1C[C@@H]2[C@H](C[C@H]1C(=O)NC(C)(C)C)CCCC2)c1ccccc1	positive	training
Neomycin	O([C@H]1[C@H](O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2N)CN)[C@@H](N)C[C@@H](N)[C@@H]1O)[C@@H]1O[C@@H]([C@@H](O[C@H]2O[C@H]([C@@H](O)[C@H](O)[C@H]2N)CN)[C@H]1O)CO	negative	training
Nepafenac	O=C(c1c(N)c(CC(=O)N)ccc1)c1ccccc1	negative	training
Netilmicin	O([C@H]1[C@H](NCC)C[C@H](N)[C@@H](O[C@H]2OC(=CC[C@H]2N)CN)[C@@H]1O)[C@H]1OC[C@](O)([C@H](NC)[C@H]1O)C	positive	training
Nevirapine	O=c1[nH]c2c(n(C3CC3)c3ncccc13)nccc2C	positive	black|NE
Niacin	OC(=O)c1cccnc1	positive	pairs
Niacinamide	O=C(N)c1cccnc1	positive	training
Nicardipine	O(C(=O)C1=C(NC(=C([C@H]1c1cc(N(=O)=O)ccc1)C(=O)OC)C)C)CCN(Cc1ccccc1)C	negative	external
Niclosamide	Clc1c(NC(=O)c2c(O)ccc(Cl)c2)ccc(N(=O)=O)c1	negative	training
Nicotine	N1([C@@H](CCC1)c1cccnc1)C	negative	training
Nifedipine	O(C(=O)C1=C(NC(=C([C@H]1c1c(N(=O)=O)cccc1)C(=O)OC)C)C)C	positive	training
Niflumic	FC(F)(F)c1cc(Nc2ncccc2C(=O)O)ccc1	positive	training
Nilutamide	FC(F)(F)c1cc(N2C(=O)C(NC2=O)(C)C)ccc1N(=O)=O	positive	external
Nilvadipine	O(C(=O)C1=C(NC(=C([C@H]1c1cc(N(=O)=O)ccc1)C(=O)OC)C#N)C)C(C)C	positive	training
Nimesulide	S(=O)(=O)(Nc1c(Oc2ccccc2)cc(N(=O)=O)cc1)C	positive	training
Nimodipine	O(C(=O)C1=C(NC(=C([C@H]1c1cc(N(=O)=O)ccc1)C(=O)OCCOC)C)C)C(C)C	positive	training
Nisoldipine	O(C(=O)C1=C(NC(=C([C@H]1c1c(N(=O)=O)cccc1)C(=O)OC)C)C)CC(C)C	negative	external
Nitazoxanide	s1c(NC(=O)c2c(OC(=O)C)cccc2)ncc1N(=O)=O	positive	external
Nitisinone	FC(F)(F)c1cc(N(=O)=O)c(C(=O)C2C(=O)CCCC2=O)cc1	negative	external
Nitramine	O=N(=O)c1c(N(N(=O)=O)C)c(N(=O)=O)cc(N(=O)=O)c1	positive	training
Nitrendipine	O(C(=O)C1=C(NC(=C([C@H]1c1cc(N(=O)=O)ccc1)C(=O)OC)C)C)CC	positive	training
Nitrofurantoin	o1c(/C=N/N2CC(=O)NC2=O)ccc1N(=O)=O	positive	training
Nitrofurazone	o1c(ccc1N(=O)=O)/C=N/NC(=O)N	negative	training
Nitroglycerin	O(N(=O)=O)C(CON(=O)=O)CON(=O)=O	negative	training
Nizatidine	S(CCN/C(=C/N(=O)=O)/NC)Cc1nc(sc1)CN(C)C	positive	training
N-nitrosodimethylamine	O=NN(C)C	positive	training
Nolatrexed	S(c1c2c([nH]c(nc2=O)N)ccc1C)c1ccncc1	positive	training
Nonoxynol	O(c1ccc(CCCCCCCCC)cc1)CCO	negative	external
Norepinephrine	O[C@H](c1cc(O)c(O)cc1)CN	negative	training
Norethindrone	O[C@@]1([C@@]2([C@H]([C@H]3[C@H](CC2)[C@@H]2C(=CC(=O)CC2)CC3)CC1)C)C#C	positive	training
Norfloxacin	Fc1c(N2CCNCC2)cc2n(CC)cc(c(=O)c2c1)C(=O)O	positive	training
Nortriptyline	N(CC/C=C\1/c2c(CCc3c1cccc3)cccc2)C	positive	training
Novobiocin	O1C([C@H](OC)[C@@H](OC(=O)N)[C@@H](O)[C@@H]1Oc1c(c2oc(O)c(NC(=O)c3cc(CC=C(C)C)c(O)cc3)c(=O)c2cc1)C)(C)C	positive	training
Nystatin	O1[C@@]2(O)C[C@@H](O)[C@H]([C@H]1C[C@H](O[C@H]1O[C@@H]([C@@H](O)[C@H](N)[C@@H]1O)C)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@@H]([C@@H](O)[C@H]([C@@H](OC(=O)C[C@@H](O)C[C@@H](O)C[C@@H](O)CC[C@@H](O)[C@@H](O)C2)C)C)C)C(=O)O	negative	training
Octreotide	S1SC[C@@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](Cc2c3c([nH]c2)cccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C1)C(=O)N[C@@H]([C@H](O)C)CO)Cc1ccccc1	positive	training
O-dichlorobenzene	Clc1c(Cl)cccc1	positive	training
Ofloxacin	Fc1c(N2CCN(CC2)C)c2OC[C@H](n3c2c(c1)c(=O)c(c3)C(=O)O)C	positive	external
Olanzapine	s1c2=Nc3c(NC(=c2cc1C)N1CCN(CC1)C)cccc3	positive	training
Olopatadine	O1c2c(/C(=C\CCN(C)C)/c3c(C1)cccc3)cc(cc2)CC(=O)O	negative	training
Olsalazine	Oc1c(cc(N/N=C/2\C=C(C(=O)C=C2)C(=O)O)cc1)C(=O)O	positive	training
Omeprazole	[S@](=O)(Cc1ncc(c(OC)c1C)C)c1[nH]c2c(n1)ccc(OC)c2	positive	pairs
Ondansetron	O=C1[C@H](CCc2n(c3c(c12)cccc3)C)Cn1c(ncc1)C	positive	training
Opipramol	OCCN1CCN(CC1)CCCN1c2c(C=Cc3c1cccc3)cccc2	positive	training
Orlistat	O1[C@H]([C@H](CCCCCC)C1=O)C[C@@H](OC(=O)[C@@H](NC=O)CC(C)C)CCCCCCCCCCC	positive	training
Orphenadrine	O([C@@H](c1c(cccc1)C)c1ccccc1)CCN(C)C	negative	black|NE
Oseltamivir	O([C@H]1[C@H](NC(=O)C)[C@@H](N)CC(=C1)C(=O)OCC)C(CC)CC	positive	training
Oxacillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)c1c(noc1C)c1ccccc1	positive	training
Oxamniquine	OCc1cc2CC[C@H](Nc2cc1N(=O)=O)CNC(C)C	positive	training
Oxandrolone	O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)CC(=O)OC4)C)CC2)CC1)C)C	positive	training
Oxaprozin	o1c(c(nc1CCC(=O)O)c1ccccc1)c1ccccc1	positive	training
Oxatomide	O=c1n(CCCN2CCN(CC2)[C@@H](c2ccccc2)c2ccccc2)c2c([nH]1)cccc2	positive	external
Oxazepam	Clc1cc2C(=N[C@H](O)C(=O)Nc2cc1)c1ccccc1	positive	training
Oxcarbazepine	O=C1Cc2c(N(c3c1cccc3)C(=O)N)cccc2	positive	training
Oxiconazole	Clc1c(/C(=N/OCc2c(Cl)cc(Cl)cc2)/Cn2ccnc2)ccc(Cl)c1	negative	training
Oxprenolol	O(C[C@@H](O)CNC(C)C)c1c(OCC=C)cccc1	negative	training
Oxybutynin	O[C@@](C1CCCCC1)(c1ccccc1)C(=O)OCC#CCN(CC)CC	negative	training
Oxycodone	O1[C@@H]2[C@]34[C@](O)([C@H](N(CC3)C)Cc3c4c1c(OC)cc3)CCC2=O	negative	training
Oxymetazoline	Oc1c(C(C)(C)C)cc(c(c1C)CC1=NCCN1)C	negative	training
Oxymetholone	O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)CC(=O)/C(=C\O)/C4)C)CC2)CC1)C)C	positive	training
Oxymorphone	O1[C@@H]2[C@]34[C@](O)([C@H](N(CC3)C)Cc3c4c1c(O)cc3)CCC2=O	negative	training
Oxyphencyclimine	O[C@@](C1CCCCC1)(c1ccccc1)C(=O)OCC1=NCCCN1C	negative	training
Oxyphenisatin	O=C1Nc2c([C@@]1(c1ccc(O)cc1)c1ccc(O)cc1)cccc2	positive	training
Oxytetracycline	O[C@@H]1[C@@H]2[C@](O)(C(=O)C3=C(O)c4c([C@@](O)([C@@H]13)C)cccc4O)C(=O)/C(=C(\O)/N)/C(=O)[C@H]2N(C)C	positive	external
Oxytocin	S1SC[C@H](N)C(=O)N[C@@H](C(=O)N[C@@H]([C@@H](CC)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)Cc1ccc(O)cc1	positive	training
"P,p'-diaminodiphenylmethane"	C(c1ccc(cc1)N)c1ccc(cc1)N	positive	training
Paclitaxel	O1[C@H]2[C@](OC(=O)C)([C@@H]3[C@@]([C@@H](O)C2)(C(=O)[C@H](OC(=O)C)C2=C([C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@H]3OC(=O)c3ccccc3)C2(C)C)C)C)C1	positive	training
Paliperidone	Fc1cc2onc([C@H]3CCN(CC3)CCc3c(=O)n4CCC[C@H](O)c4nc3C)c2cc1	negative	training
Palonosetron	O=C1N([C@H]2[C@@H]3CCN(C2)CC3)C[C@H]2c3c1cccc3CCC2	positive	training
Pamidronate	P(=O)(O)(O)C(P(=O)(O)O)(O)CCN	negative	training
Pancuronium	O([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)C[C@H](OC(=O)C)[C@@H]([N+]3(CCCCC3)C)C4)C)CC2)C[C@@H]1[N+]1(CCCCC1)C)C)C(=O)C	positive	training
Pantoprazole	[S@](=O)(c1[nH]c2c(n1)ccc(OC(F)F)c2)Cc1nccc(OC)c1OC	positive	training
Papaverine	O(c1cc2c(nccc2cc1OC)Cc1cc(OC)c(OC)cc1)C	positive	training
Paramethadione	O1[C@@](CC)(C(=O)N(C1=O)C)C	positive	training
Paraquat	[n+]1(ccc(c2cc[n+](cc2)C)cc1)C	positive	external
Paricalcitol	OC([C@H](/C=C/[C@H]([C@@H]1[C@@]2([C@@H](CC1)/C(=C/C=C\1/C[C@@H](O)C[C@H](O)C1)/CCC2)C)C)C)(C)C	negative	training
Paromomycin	O([C@H]1[C@H](O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2N)CO)[C@@H](N)C[C@@H](N)[C@@H]1O)[C@@H]1O[C@@H]([C@@H](O[C@H]2O[C@H]([C@@H](O)[C@H](O)[C@H]2N)CN)[C@H]1O)CO	negative	training
Paroxetine	Fc1ccc([C@H]2[C@@H](CNCC2)COc2cc3OCOc3cc2)cc1	positive	training
Pazopanib	S(=O)(=O)(N)c1c(ccc(Nc2nc(N(c3cc4nn(c(c4cc3)C)C)C)ccn2)c1)C	positive	training
P-dimethylaminoazobenzene	N(c1ccc(/N=N/c2ccccc2)cc1)(C)C	positive	training
Pefloxacin	Fc1c(N2CCN(CC2)C)cc2n(CC)cc(c(=O)c2c1)C(=O)O	positive	training
Pegaptanib	P(=O)(OCCCCCNC(=O)[C@@H](NC(=O)OCCOC)CCCCNC(=O)OCCOC)(O)C	negative	training
Pemetrexed	O=c1nc([nH]c2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(=O)O)C(=O)O)c12)N	positive	training
Pemirolast	O=c1n2c(ncc1c1n[nH]nn1)c(ccc2)C	positive	training
Pemoline	O1[C@@H](c2ccccc2)C(=O)N=C1N	positive	black|NE
Penbutolol	O(c1c(C2CCCC2)cccc1)C[C@@H](O)CNC(C)(C)C	negative	training
Penciclovir	OCC(CCn1c2[nH]c(nc(=O)c2nc1)N)CO	negative	training
Penfluridol	Clc1c(cc([C@]2(O)CCN(CC2)CCC[C@@H](c2ccc(F)cc2)c2ccc(F)cc2)cc1)C(F)(F)F	negative	training
Penicillamine	SC([C@@H](N)C(=O)O)(C)C	positive	training
Penicillin g benzathine	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)Cc1ccccc1	positive	training
Penicillin v	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)COc1ccccc1	positive	training
Pentachloroethane	ClC(Cl)(Cl)C(Cl)Cl	positive	training
Pentagastrin	S(CC[C@H](NC(=O)[C@@H](NC(=O)CCNC(=O)OCC(C)C)Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N)C	negative	training
Pentamidine	O(CCCCCOc1ccc(cc1)C(=N)N)c1ccc(cc1)C(=N)N	positive	training
Pentazocine	Oc1cc2[C@]3([C@H]([C@H](N(CC3)CC=C(C)C)Cc2cc1)C)C	negative	training
Pentobarbital	O=C1NC(=O)NC(=O)C1([C@@H](CCC)C)CC	negative	training
Pentosan polysulfate sodium	S(=O)(=O)(O)c1cc(c(cc1)C)C	positive	external
Pentostatin	O1[C@@H](n2c3NC=NC[C@@H](O)c3nc2)C[C@H](O)[C@H]1CO	positive	training
Pentoxifylline	O=c1n(CCCCC(=O)C)c(=O)n(c2ncn(c12)C)C	positive	external
Peplomycin	s1c(nc(c1)c1scc(n1)C(=O)NCCCN[C@H](c1ccccc1)C)CCNC(=O)[C@@H](NC(=O)[C@@H]([C@@H](O)[C@H](NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](NC[C@H](N)C(=O)N)CC(=O)N)[C@H](O[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@@H]([C@@H](O)[C@H](OC(=O)N)[C@@H]1O)CO)CO)c1[nH]cnc1)C)C)[C@H](O)C	positive	training
Perazine	S1c2c(N(CCCN3CCN(CC3)C)c3c1cccc3)cccc2	positive	training
Perflubron	BrC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	positive	external
Pergolide	S(C[C@@H]1C[C@H]2[C@H](N(C1)CCC)Cc1c3c2cccc3[nH]c1)C	negative	training
Perhexiline	N1[C@@H](CC(C2CCCCC2)C2CCCCC2)CCCC1	positive	external
Periciazine	S1c2c(N(CCCN3CC[C@H](O)CC3)c3c1cccc3)cc(cc2)C#N	positive	training
Perindopril	O=C(N1[C@@H]2[C@H](C[C@H]1C(=O)O)CCCC2)[C@@H](N[C@@H](CCC)C(=O)OCC)C	negative	external
Permethrin	ClC(=C[C@H]1C([C@@H]1C(=O)OCc1cc(Oc2ccccc2)ccc1)(C)C)Cl	negative	training
Perphenazine	Clc1cc2N(CCCN3CCN(CC3)CCO)c3c(Sc2cc1)cccc3	positive	training
Phenacemide	O=C(NC(=O)N)Cc1ccccc1	positive	training
Phendimetrazine	O1[C@@H]([C@H](N(CC1)C)C)c1ccccc1	negative	training
Phenelzine	N(N)CCc1ccccc1	positive	training
Phenindione	O=C1[C@@H](C(=O)c2c1cccc2)c1ccccc1	positive	training
Phenmetrazine	O1[C@@H]([C@H](NCC1)C)c1ccccc1	negative	training
Phenobarbital	O=C1NC(=O)NC(=O)C1(CC)c1ccccc1	positive	training
Phenol	Oc1ccccc1	positive	training
Phenoxybenzamine	ClCCN([C@@H](COc1ccccc1)C)Cc1ccccc1	negative	training
Phenprocoumon	o1c(O)c([C@H](CC)c2ccccc2)c(=O)c2c1cccc2	negative	training
Phentermine	NC(Cc1ccccc1)(C)C	negative	training
Phentolamine	Oc1cc(N(CC2=NCCN2)c2ccc(cc2)C)ccc1	negative	training
Phenylbutazone	O=C1N(N(C(=O)[C@H]1CCCC)c1ccccc1)c1ccccc1	positive	training
Phenytoin	O=C1NC(=O)N[C@@]1(c1ccccc1)c1ccccc1	positive	training
Phytonadione	O=C1C(=C(C(=O)c2c1cccc2)C)C/C=C(/CCC[C@H](CCC[C@@H](CCCC(C)C)C)C)\C	positive	training
Picric acid	Oc1c(N(=O)=O)cc(N(=O)=O)cc1N(=O)=O	positive	training
Pilocarpine	O1C[C@@H]([C@H](CC)C1=O)Cc1n(cnc1)C	negative	black|NE
Pimecrolimus	Cl[C@@H]1[C@H](OC)C[C@@H](CC1)/C=C(/[C@H]1OC(=O)[C@H]2N(C(=O)C(=O)[C@@]3(O[C@@H]([C@@H](OC)C[C@H]3C)[C@@H](OC)C[C@H](C/C(=C/[C@H](C(=O)C[C@H](O)[C@H]1C)CC)/C)C)O)CCCC2)\C	negative	training
Pinacidil	N(=C(\Nc1ccncc1)/NC#N)/[C@@H](C(C)(C)C)C	negative	black|NE
Pindolol	O(C[C@@H](O)CNC(C)C)c1c2c([nH]cc2)ccc1	positive	training
Pioglitazone	S1[C@@H](Cc2ccc(OCCc3ncc(CC)cc3)cc2)C(=O)NC1=O	positive	training
Pipecuronium	O([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)C[C@H](OC(=O)C)[C@@H](N3CC[N+](CC3)(C)C)C4)C)CC2)C[C@@H]1N1CC[N+](CC1)(C)C)C)C(=O)C	negative	training
Piperacillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C(=O)C1=O)CC)c1ccccc1	positive	training
Piperazine	N1CCNCC1	negative	training
Pipobroman	BrCCC(=O)N1CCN(CC1)C(=O)CCBr	negative	training
Pipotiazine	S1c2c(N(CCCN3CC[C@@H](CC3)CCO)c3c1cccc3)cc(S(=O)(=O)N(C)C)cc2	positive	training
Pirarubicin	O([C@H]1C[C@@](O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)c(OC)ccc2)C(=O)CO)[C@H]1O[C@@H]([C@@H](O[C@H]2OCCCC2)[C@H](N)C1)C	positive	training
Pirazolac	Clc1ccc(c2c(nn(c2)c2ccc(F)cc2)CC(=O)O)cc1	positive	training
Pirbuterol	O[C@@H](CNC(C)(C)C)c1nc(c(O)cc1)CO	negative	training
Piretanide	S(=O)(=O)(N)c1c(Oc2ccccc2)c(N2CCCC2)cc(c1)C(=O)O	positive	training
Piribedil	O1c2cc(CN3CCN(CC3)c3ncccn3)ccc2OC1	positive	training
Piritrexim	O(c1c(Cc2c(c3c(nc2)nc(nc3N)N)C)cc(OC)cc1)C	positive	external
Piroxicam	S1(=O)(=O)N(/C(=C(/O)\Nc2ncccc2)/C(=O)c2c1cccc2)C	positive	training
Pirprofen	Clc1c(N2CC=CC2)ccc([C@@H](C)C(=O)O)c1	positive	training
Plerixafor	N1(CCCNCCNCCCNCC1)Cc1ccc(CN2CCCNCCNCCCNCC2)cc1	negative	training
Plicamycin	O([C@@H]1C[C@H](O[C@H]2[C@@H](Cc3c(C2=O)c(O)c2c(c3)cc(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)C4)C)C3)C)c(c2O)C)[C@H](OC)C(=O)[C@@H](O)[C@H](O)C)O[C@@H]([C@H]1O)C)[C@@H]1O[C@@H]([C@@H](O)[C@H](O[C@@H]2O[C@@H]([C@@H](O)[C@@](O)(C2)C)C)C1)C	positive	training
Podofilox	O1C[C@H]2[C@@H]([C@@H](c3c([C@@H]2O)cc2OCOc2c3)c2cc(OC)c(OC)c(OC)c2)C1=O	negative	training
Polymyxin b	O=C1N[C@@H](CCN)C(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@H](O)C)C(=O)NCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCCC[C@@H](CC)C)CCN)[C@H](O)C)CCN)C(=O)N[C@@H](CCN)C(=O)N[C@@H](C(=O)N[C@H]1CC(C)C)Cc1ccccc1	negative	training
Polystyrene sulfonate	S(=O)(=O)(O)c1c(cccc1)C=C	negative	training
Polythiazide	Clc1cc2N[C@H](N(S(=O)(=O)c2cc1S(=O)(=O)N)C)CSCC(F)(F)F	negative	training
Porfimer	O([C@@H](c1c2[nH]c(c1C)/C=C/1\N=C(C(=C1C)CCC(=O)O)/C=C\1/N=C(/C=c/3\[nH]/c(=C\2)/c(c3[C@H](O)C)C)C(=C1CCC(=O)O)C)C)[C@@H](c1c(/c/2=C/c3[nH]c(c(c3[C@H](O)C)C)/C=C/3\N=C(C(=C3C)CCC(=O)O)/C=C/3\N=C(/C=c/1\[nH]2)C(=C3CCC(=O)O)C)C)C	positive	training
Posaconazole	Fc1c([C@@]2(OC[C@H](C2)COc2ccc(N3CCN(CC3)c3ccc(n4c(=O)n(nc4)[C@H]([C@@H](O)C)CC)cc3)cc2)Cn2ncnc2)ccc(F)c1	positive	training
Prajmaline	O[C@H]1[C@@]23[C@H](N(c4c3cccc4)C)[C@@H]3N([C@@H]([C@H]1[C@@H](C3)[C@@H](CC)C=O)C2)CCC	positive	external
Pralidoxime	O=N/C=c\1/n(cccc1)C	negative	training
Pramlintide	SC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)CS)CC(=O)N)[C@H](O)C)C)[C@H](O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N)CC(C)C)[C@H](CC)C)Cc1ccccc1)CC(=O)N)CC(=O)N)CO)CO)Cc1[nH]cnc1)C(C)C)CC(C)C)Cc1ccccc1)CC(=O)N)C)CCC(=O)N)[C@H](O)C)C	negative	training
Pranlukast	O(CCCCc1ccccc1)c1ccc(cc1)C(=O)Nc1cc2oc(cc(=O)c2cc1)c1n[nH]nn1	positive	training
Pravastatin	O([C@@H]1[C@@H]2[C@H]([C@H](C=CC2=C[C@@H](O)C1)C)CC[C@@H](O)C[C@@H](O)CC(=O)O)C(=O)[C@H](CC)C	positive	external
Prazepam	Clc1cc2c(N(CC3CC3)C(=O)CN=C2c2ccccc2)cc1	negative	external
Praziquantel	O=C(N1C[C@@H]2N(CCc3c2cccc3)C(=O)C1)C1CCCCC1	positive	training
Prazosin	O=C(N1CCN(CC1)c1nc2c(c(n1)N)cc(OC)c(OC)c2)c1occc1	positive	training
Prednicarbate	O([C@]1([C@@]2([C@H]([C@H]3[C@H]([C@@H](O)C2)[C@@]2(C(=CC(=O)C=C2)CC3)C)CC1)C)C(=O)COC(=O)CC)C(=O)OCC	negative	training
Pregabalin	OC(=O)C[C@H](CC(C)C)CN	positive	training
Prilocaine	O=C(Nc1c(cccc1)C)[C@H](NCCC)C	negative	training
Primaquine	O(c1cc(N[C@@H](CCCN)C)c2ncccc2c1)C	negative	training
Primidone	O=C1NCNC(=O)C1(CC)c1ccccc1	negative	black|NE
Probenecid	S(=O)(=O)(N(CCC)CCC)c1ccc(cc1)C(=O)O	positive	training
Probucol	S(c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)C(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)(C)C	positive	training
Procainamide	O=C(NCCN(CC)CC)c1ccc(N)cc1	positive	training
Procaine	O(CCN(CC)CC)C(=O)c1ccc(N)cc1	negative	training
Procarbazine	O=C(NC(C)C)c1ccc(CNNC)cc1	positive	training
Prochlorperazine	Clc1cc2N(CCCN3CCN(CC3)C)c3c(Sc2cc1)cccc3	positive	training
Procyclidine	O[C@@](C1CCCCC1)(CCN1CCCC1)c1ccccc1	negative	training
Progabide	Clc1ccc(/C(=C\2/C=C(F)C=CC2=O)/NCCCC(=O)N)cc1	positive	training
Progesterone	O=C([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C)C	positive	training
Promazine	S1c2c(N(CCCN(C)C)c3c1cccc3)cccc2	positive	training
Promethazine	S1c2c(N(C[C@H](N(C)C)C)c3c1cccc3)cccc2	positive	external
Propafenone	O(C[C@@H](O)CNCCC)c1c(C(=O)CCc2ccccc2)cccc1	positive	training
Propantheline	O(CC[N+](C(C)C)(C(C)C)C)C(=O)[C@H]1c2c(Oc3c1cccc3)cccc2	negative	training
Proparacaine	O(CCN(CC)CC)C(=O)c1cc(N)c(OCCC)cc1	negative	training
Propiomazine	S1c2c(N(C[C@H](N(C)C)C)c3c1cccc3)cc(cc2)C(=O)CC	negative	training
Propofol	Oc1c(C(C)C)cccc1C(C)C	positive	training
Propoxyphene	O([C@@]([C@@H](CN(C)C)C)(Cc1ccccc1)c1ccccc1)C(=O)CC	positive	training
Propranolol	O(C[C@@H](O)CNC(C)C)c1c2c(ccc1)cccc2	positive	training
Propylene dichloride	Cl[C@@H](CCl)C	positive	training
Propyliodone	Ic1cn(CC(=O)OCCC)cc(I)c1=O	negative	training
Propylthiouracil	S=c1[nH]c(CCC)cc(=O)[nH]1	positive	training
Protirelin	O=C(N1[C@@H](CCC1)C(=O)N)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1	negative	training
Protriptyline	N(CCC[C@H]1c2c(C=Cc3c1cccc3)cccc2)C	positive	training
Pseudoephedrine	O[C@H]([C@@H](NC)C)c1ccccc1	negative	black|NE
Pyrazinamide	O=C(N)c1nccnc1	positive	training
Pyridine	n1ccccc1	positive	training
Pyridostigmine	O(c1c[n+](ccc1)C)C(=O)N(C)C	negative	black|NE
Pyridoxine	Oc1c(c(CO)cnc1C)CO	negative	black|NE
Pyrimethamine	Clc1ccc(c2c(nc(nc2N)N)CC)cc1	negative	training
Pyrvinium	n1(c(c(cc1C)/C=C/c1[n+](c2c(cc(N(C)C)cc2)cc1)C)C)c1ccccc1	negative	training
Quazepam	Clc1cc2c(N(CC(F)(F)F)C(=S)CN=C2c2c(F)cccc2)cc1	negative	training
Quetiapine	S1c2c(C(=Nc3c1cccc3)N1CCN(CC1)CCOCCO)cccc2	positive	training
Quinacrine	Clc1cc2nc3c(c(N[C@@H](CCCN(CC)CC)C)c2cc1)cc(OC)cc3	positive	training
Quinapril	O=C(N1[C@@H](Cc2c(C1)cccc2)C(=O)O)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	negative	training
Quinestrol	O[C@@]1([C@@]2([C@H]([C@H]3[C@H](CC2)c2c(CC3)cc(OC3CCCC3)cc2)CC1)C)C#C	positive	training
Quinethazone	Clc1c(S(=O)(=O)N)cc2c(N[C@@H](NC2=O)CC)c1	positive	training
Quinidine	O[C@H]([C@@H]1N2C[C@@H]([C@H](C1)CC2)C=C)c1c2c(ncc1)ccc(OC)c2	positive	training
Quinine	O[C@@H]([C@H]1N2C[C@@H]([C@@H](C1)CC2)C=C)c1c2c(ncc1)ccc(OC)c2	positive	training
Raloxifene	s1c(c(c2c1cc(O)cc2)C(=O)c1ccc(OCCN2CCCCC2)cc1)c1ccc(O)cc1	positive	training
Raltitrexed	s1c(N(Cc2cc3c([nH]c(nc3=O)C)cc2)C)ccc1C(=O)N[C@@H](CCC(=O)O)C(=O)O	positive	external
Ramelteon	O1c2c(c3[C@@H](CCc3cc2)CCNC(=O)CC)CC1	negative	training
Ramipril	O=C(N1[C@@H]2[C@H](C[C@H]1C(=O)O)CCC2)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	positive	training
Ranitidine	S(Cc1oc(CN(C)C)cc1)CCN/C(=C/N(=O)=O)/NC	positive	external
Ranolazine	O[C@@H](CN1CCN(CC1)CC(=O)Nc1c(cccc1C)C)COc1c(OC)cccc1	negative	training
Rapacuronium	O([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)C[C@H](OC(=O)C)[C@@H](N3CCCCC3)C4)C)CC2)C[C@@H]1[N+]1(CCCCC1)CC=C)C)C(=O)CC	negative	training
Rasagiline	N([C@@H]1CCc2c1cccc2)CC#C	negative	training
Regadenoson	O1[C@@H](n2c3nc(nc(N)c3nc2)n2ncc(c2)C(=O)NC)[C@H](O)[C@H](O)[C@H]1CO	negative	external
Remifentanil	O(C(=O)C1(N(c2ccccc2)C(=O)CC)CCN(CC1)CCC(=O)OC)C	negative	external
Repaglinide	O=C(N[C@H](c1c(N2CCCCC2)cccc1)CC(C)C)Cc1cc(OCC)c(cc1)C(=O)O	negative	external
Rescinnamine	O([C@@H]1[C@H]([C@@H]2[C@@H](CN3[C@H](C2)c2[nH]c4c(c2CC3)ccc(OC)c4)C[C@H]1OC(=O)/C=C/c1cc(OC)c(OC)c(OC)c1)C(=O)OC)C	negative	training
Reserpine	O([C@@H]1[C@H]([C@@H]2[C@@H](CN3[C@H](C2)c2[nH]c4c(c2CC3)ccc(OC)c4)C[C@H]1OC(=O)c1cc(OC)c(OC)c(OC)c1)C(=O)OC)C	negative	training
Resorcinol	Oc1cc(O)ccc1	positive	training
Retapamulin	S([C@H]1C[C@@H]2N([C@H](C1)CC2)C)CC(=O)O[C@H]1[C@@]2([C@H]3[C@@]([C@H]([C@H](O)[C@](C1)(C)C=C)C)(CC[C@H]2C)CCC3=O)C	negative	training
Ribavirin	O1[C@@H]([C@@H](O)[C@@H](O)[C@@H]1n1nc(nc1)C(=O)N)CO	positive	training
Rifabutin	O([C@H]1[C@@H]([C@H](O)[C@@H]([C@@H](O)[C@@H](C)/C=C/C=C(\C(=O)NC2=C3NC4(N=C3c3c(C2=O)c(O)c(c2O[C@](O/C=C/[C@H](OC)[C@H]1C)(C(=O)c32)C)C)CCN(CC4)CC(C)C)/C)C)C)C(=O)C	positive	training
Rifampin	O([C@H]1[C@@H]([C@@H](O)[C@H]([C@H](O)[C@@H](C)/C=C/C=C(\C(=O)NC2=C(O)c3c(c4C(=O)[C@](O/C=C/[C@@H](OC)[C@@H]1C)(Oc4c(c3O)C)C)C(=O)/C/2=C/NN1CCN(CC1)C)/C)C)C)C(=O)C	positive	training
Rifapentine	O([C@H]1[C@@H]([C@H](O)[C@@H]([C@@H](O)[C@@H](C)/C=C/C=C(/C(=O)NC2=C(O)c3c(C(=O)/C/2=C/NN2CCN(C4CCCC4)CC2)c2c(O[C@](O/C=C/[C@H](OC)[C@H]1C)(C2=O)C)c(c3O)C)\C)C)C)C(=O)C	positive	training
Riluzole	s1c2c(nc1N)ccc(OC(F)(F)F)c2	positive	training
Rimantadine	N[C@@H]([C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)C3)C	negative	training
Rimexolone	O[C@@H]1[C@H]2[C@H]([C@H]3[C@@]([C@@]([C@@H](C3)C)(C)C(=O)CC)(C1)C)CCC1=CC(=O)C=C[C@]21C	negative	training
Risedronate	P(=O)(O)(O)C(P(=O)(O)O)(O)Cc1cccnc1	negative	external
Risperidone	Fc1cc2onc([C@H]3CCN(CC3)CCc3c(=O)n4CCCCc4nc3C)c2cc1	positive	training
Ritodrine	O[C@@H]([C@@H](NCCc1ccc(O)cc1)C)c1ccc(O)cc1	positive	training
Ritonavir	s1c(nc(CN(C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@@H](NC(=O)OCc2scnc2)Cc2ccccc2)Cc2ccccc2)C)c1)C(C)C	positive	training
Rivastigmine	O(c1cc([C@@H](N(C)C)C)ccc1)C(=O)N(CC)C	negative	training
Rizatriptan	[nH]1c2c(c(CCN(C)C)c1)cc(cc2)Cn1ncnc1	negative	training
Rocuronium	O([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)C[C@H](O)[C@@H](N3CCOCC3)C4)C)CC2)C[C@@H]1[N+]1(CCCC1)CC=C)C)C(=O)C	negative	training
Rofecoxib	S(=O)(=O)(c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1)C	positive	external
Ronnel	Clc1c(OP(=S)(OC)OC)cc(Cl)c(Cl)c1	positive	training
Ropinirole	O=C1Nc2c(c(CCN(CCC)CCC)ccc2)C1	negative	training
Ropivacaine	O=C(Nc1c(cccc1C)C)[C@H]1N(CCCC1)CCC	negative	training
Rosiglitazone	S1[C@@H](Cc2ccc(OCCN(c3ncccc3)C)cc2)C(=O)NC1=O	positive	training
Rosuvastatin	S(=O)(=O)(N(c1nc(C(C)C)c(c(n1)c1ccc(F)cc1)/C=C/[C@H](O)C[C@@H](O)CC(=O)O)C)C	positive	training
Rotigotine	s1c(CCN([C@H]2CCc3c(C2)cccc3O)CCC)ccc1	negative	training
Roxatidine	O(c1cc(CN2CCCCC2)ccc1)CCCNC(=O)COC(=O)C	positive	training
Roxithromycin	O([C@@H]1[C@H]([C@H](O[C@@H]2O[C@H]([C@H](O)[C@](OC)(C2)C)C)[C@H](C(=O)O[C@@H]([C@@](O)([C@H](O)[C@H](/C(=N/OCOCCOC)/[C@@H](C[C@]1(O)C)C)C)C)CC)C)C)[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C	positive	training
Rufinamide	Fc1c(Cn2nnc(c2)C(=O)N)c(F)ccc1	negative	training
Sacrosidase	O1c2cc(C(C)(C)C)ccc2O[C@H]1C	negative	training
Salmeterol	O(CCCCCCNC[C@H](O)c1cc(c(O)cc1)CO)CCCCc1ccccc1	negative	training
Salsalate	O(c1c(cccc1)C(=O)O)C(=O)c1c(O)cccc1	positive	training
Samarium sm 153 lexidronam	P(=O)(O)(O)CN(CCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O	negative	training
Sapropterin	O[C@H]([C@@H]1Nc2c(NC1)[nH]c(nc2=O)N)[C@@H](O)C	negative	training
Saquinavir	O=C(NC(C)(C)C)[C@H]1N(C[C@@H]2[C@H](C1)CCCC2)C[C@@H](O)[C@@H](NC(=O)[C@@H](NC(=O)c1nc2c(cc1)cccc2)CC(=O)N)Cc1ccccc1	positive	training
Secobarbital	O=C1NC(=O)NC(=O)C1([C@@H](CCC)C)CC=C	negative	training
Secretin	O=C(N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](N)Cc1[nH]ccn1)CO)CC(=O)O)[C@H](O)C)Cc1ccccc1)[C@H](O)C)CO)CCC(=O)O)CC(C)C)CO)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)CC(=O)O)CO)C)CCCNC(=N)N)CC(C)C)CCC(=O)N)CCCNC(=N)N)CC(C)C	negative	training
Selegiline	N([C@@H](Cc1ccccc1)C)(CC#C)C	negative	training
Seratrodast	O=C1C(=C(C(=O)C(=C1C)C)C)[C@H](CCCCCC(=O)O)c1ccccc1	positive	external
Sermorelin	S(CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C)CC(=O)O)C)[C@@H](CC)C)Cc1ccccc1)[C@H](O)C)CC(=O)N)CO)Cc1ccc(O)cc1)CCCNC(=N)N)CCCCN)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CO)C)CCCNC(=N)N)CCCCN)CC(C)C)CC(C)C)CCC(=O)N)CC(=O)O)[C@@H](CC)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)C	negative	training
Sertaconazole	Clc1c([C@@H](OCc2c3c(sc2)c(Cl)ccc3)Cn2ccnc2)ccc(Cl)c1	positive	training
Sertraline	Clc1cc([C@@H]2CC[C@H](NC)c3c2cccc3)ccc1Cl	positive	training
Sevoflurane	FC(F)(F)C(OCF)C(F)(F)F	positive	external
Sibutramine	Clc1ccc(C2(CCC2)[C@H](N(C)C)CC(C)C)cc1	positive	training
Sildenafil	S(=O)(=O)(N1CCN(CC1)C)c1cc(c2[nH]c3c(nn(c3c(=O)n2)C)CCC)c(OCC)cc1	positive	training
Silodosin	FC(F)(F)COc1c(OCCN[C@@H](Cc2cc3c(N(CC3)CCCO)c(c2)C(=O)N)C)cccc1	positive	training
Silver sulfadiazine	S(=O)(=O)([N-]c1ncccn1)c1ccc(N)cc1	negative	training
Simvastatin	O([C@@H]1[C@@H]2[C@H]([C@H](C=CC2=C[C@@H](C1)C)C)CC[C@H]1OC(=O)C[C@H](O)C1)C(=O)C(CC)(C)C	positive	training
Sincalide	S(CC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)Cc1ccc(OS(=O)(=O)O)cc1)CCSC)Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N)C	negative	training
Sirolimus	O([C@@H]1C[C@@H](CC[C@H]1O)C[C@H]([C@H]1OC(=O)[C@H]2N(CCCC2)C(=O)C(=O)[C@@]2(O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C\[C@H](C[C@H](C(=O)[C@H](OC)[C@H](O)/C(=C/[C@H](C(=O)C1)C)/C)C)C)/C)O)C)C	positive	external
Sodium phenylbutyrate	OC(=O)CCCc1ccccc1	positive	training
Solifenacin	O([C@H]1[C@@H]2CCN(C1)CC2)C(=O)N1[C@H](c2c(CC1)cccc2)c1ccccc1	negative	training
Sorafenib	Clc1c(cc(NC(=O)Nc2ccc(Oc3cc(ncc3)C(=O)NC)cc2)cc1)C(F)(F)F	positive	training
Sorbitol	O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO	negative	training
Sotalol	S(=O)(=O)(Nc1ccc([C@@H](O)CNC(C)C)cc1)C	positive	training
Sparfloxacin	Fc1c2n(C3CC3)cc(c(=O)c2c(N)c(F)c1N1C[C@@H](N[C@@H](C1)C)C)C(=O)O	positive	external
Spectinomycin	O1[C@H]2[C@H](O[C@@H]3O[C@@H](CC(=O)[C@]13O)C)[C@@H](O)[C@H](NC)[C@H](O)[C@@H]2NC	positive	training
Spironolactone	S([C@H]1[C@H]2[C@H]3[C@@]([C@@]4(OC(=O)CC4)CC3)(CC[C@@H]2[C@@]2(C(=CC(=O)CC2)C1)C)C)C(=O)C	positive	external
Stanozolol	O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)Cc3[nH]ncc3C4)C)CC2)CC1)C)C	positive	training
Stavudine	O1[C@@H](n2cc(c(=O)[nH]c2=O)C)C=C[C@H]1CO	positive	training
Streptokinase	OC(=O)[C@H]1NC[C@@H](C2CCCCC2)C1	positive	external
Streptomycin	O([C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O)[C@@H]1O[C@H]([C@@](O)([C@H]1O[C@@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1NC)CO)C=O)C	negative	training
Streptozocin	O1[C@@H]([C@@H](O)[C@H](O)[C@@H](NC(=O)N(N=O)C)[C@H]1O)CO	positive	training
Styrene	c1(ccccc1)C=C	positive	training
Succimer	S[C@@H]([C@H](S)C(=O)O)C(=O)O	positive	training
Succinylcholine	O(CC[N+](C)(C)C)C(=O)CCC(=O)OCC[N+](C)(C)C	negative	training
Sucralfate	S(=O)(=O)(O[C@@H]1[C@](O[C@@H]2O[C@@H]([C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)COS(=O)(=O)O)(O[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O)COS(=O)(=O)O)O	positive	training
Sufentanil	s1c(CCN2CC[C@](N(c3ccccc3)C(=O)CC)(CC2)COC)ccc1	negative	training
Sulconazole	Clc1c([C@@H](SCc2ccc(Cl)cc2)Cn2ccnc2)ccc(Cl)c1	negative	black|NE
Sulfacetamide	S(=O)(=O)(NC(=O)C)c1ccc(N)cc1	negative	training
Sulfacytine	S(=O)(=O)(Nc1nc(=O)n(CC)cc1)c1ccc(N)cc1	positive	training
Sulfadiazine	S(=O)(=O)(Nc1ncccn1)c1ccc(N)cc1	negative	pairs
Sulfamethizole	S(=O)(=O)(Nc1sc(nn1)C)c1ccc(N)cc1	positive	training
Sulfapyridine	S(=O)(=O)(Nc1ncccc1)c1ccc(N)cc1	positive	pairs
Sulfasalazine	S(=O)(=O)(Nc1ncccc1)c1ccc(N/N=C\2/C=C(C(=O)C=C2)C(=O)O)cc1	positive	external
Sulfinpyrazone	[S@](=O)(CC[C@H]1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1)c1ccccc1	negative	training
Sulfisoxazole	S(=O)(=O)(Nc1onc(c1C)C)c1ccc(N)cc1	positive	training
Sulindac	[S@](=O)(c1ccc(/C=C\2/C(=C(c3c2ccc(F)c3)CC(=O)O)C)cc1)C	positive	training
Sulpiride	S(=O)(=O)(N)c1cc(C(=O)NC[C@H]2N(CCC2)CC)c(OC)cc1	positive	training
Sumatriptan	S(=O)(=O)(NC)Cc1cc2c(CCN(C)C)c[nH]c2cc1	negative	black|NE
Sunitinib	Fc1cc2/C(=C\c3[nH]c(c(c3C)C(=O)NCCN(CC)CC)C)/C(=O)Nc2cc1	positive	training
Suprofen	s1c(C(=O)c2ccc([C@@H](C)C(=O)O)cc2)ccc1	positive	external
Tacrine	n1c2c(CCCC2)c(N)c2c1cccc2	positive	training
Tacrolimus	O1[C@H]2[C@@H](OC)C[C@H]([C@]1(O)C(=O)C(=O)N1[C@@H](CCCC1)C(=O)O[C@@H]([C@@H]([C@@H](O)CC(=O)[C@@H](/C=C(/C[C@@H](C[C@@H]2OC)C)\C)CC=C)C)/C(=C/[C@H]1C[C@@H](OC)[C@H](O)CC1)/C)C	positive	training
Talinolol	O=C(NC1CCCCC1)Nc1ccc(OC[C@@H](O)CNC(C)(C)C)cc1	positive	training
Tamoxifen	O(c1ccc(/C(=C(/CC)\c2ccccc2)/c2ccccc2)cc1)CCN(C)C	positive	training
Tamsulosin	S(=O)(=O)(N)c1cc(C[C@H](NCCOc2c(OCC)cccc2)C)ccc1OC	negative	training
Tapentadol	Oc1cc([C@@H]([C@H](CN(C)C)C)CC)ccc1	positive	training
Tasosartan	O=C1N(c2nc(nc(c2CC1)C)C)Cc1ccc(cc1)c1c(cccc1)c1n[nH]nn1	positive	external
Tazarotene	S1CCC(c2c1ccc(c2)C#Cc1ncc(cc1)C(=O)OCC)(C)C	negative	training
Technetium tc 99m tetrofosmin	P(CCP(CCOCC)CCOCC)(CCOCC)CCOCC	negative	training
Tegaserod	OCc1cc2c(N=C/C/2=C\NN/C(=N/CCCCC)/N)cc1	positive	training
Telbivudine	O1[C@H](n2cc(c(=O)[nH]c2=O)C)C[C@@H](O)[C@@H]1CO	positive	training
Telithromycin	O1[C@]2([C@H](N(C1=O)CCCCn1cc(nc1)c1cccnc1)[C@H](C(=O)[C@@H](C[C@@](OC)([C@H](O[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C)[C@H](C(=O)[C@H](C(=O)O[C@@H]2CC)C)C)C)C)C)C	positive	training
Telmisartan	OC(=O)c1c(c2ccc(Cn3c4c(nc3CCC)c(cc(c4)c3n(c4c(n3)cccc4)C)C)cc2)cccc1	positive	training
Temazepam	Clc1cc2c(N(C(=O)[C@@H](O)N=C2c2ccccc2)C)cc1	negative	external
Temocillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@@]2(OC)NC(=O)[C@@H](c1ccsc1)C(=O)O	negative	training
Temozolomide	O=c1n2c(nnn1C)c(nc2)C(=O)N	positive	training
Temsirolimus	O([C@H]1C[C@H](CC[C@@H]1OC(=O)C(CO)(CO)C)C[C@H]([C@H]1OC(=O)[C@H]2N(CCCC2)C(=O)C(=O)[C@@]2(O[C@@H](CC[C@H]2C)C[C@@H](OC)/C(=C/C=C/C=C\[C@H](C[C@@H](C(=O)[C@H](OC)[C@H](O)/C(=C/[C@@H](C(=O)C1)C)/C)C)C)/C)O)C)C	positive	training
Tenidap	Clc1cc2c(n(c(O)c2C(=O)c2sccc2)C(=O)N)cc1	positive	training
Teniposide	s1c([C@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@H]4[C@@H]5[C@@H]([C@@H](c6c4cc4OCOc4c6)c4cc(OC)c(O)c(OC)c4)C(=O)OC5)O[C@@H]3CO2)ccc1	positive	training
Tenofovir disoproxil fumarate	P(=O)(OCOC(=O)OC(C)C)(OCOC(=O)OC(C)C)CO[C@@H](Cn1c2ncnc(N)c2nc1)C	positive	training
Tenoxicam	S1(=O)(=O)N(/C(=C(\O)/Nc2ncccc2)/C(=O)c2sccc12)C	positive	training
Terazosin	O1[C@@H](CCC1)C(=O)N1CCN(CC1)c1nc2c(c(n1)N)cc(OC)c(OC)c2	negative	training
Terbinafine	N(Cc1c2c(ccc1)cccc2)(C/C=C/C#CC(C)(C)C)C	positive	external
Terbutaline	O[C@@H](CNC(C)(C)C)c1cc(O)cc(O)c1	positive	training
Terconazole	Clc1c([C@@]2(O[C@H](CO2)COc2ccc(N3CCN(CC3)C(C)C)cc2)Cn2ncnc2)ccc(Cl)c1	negative	external
Teriparatide	S(CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)CO)CCC(=O)O)[C@H](CC)C)CCC(=O)N)CC(C)C)C(=O)N[C@@H](Cc1nc[nH]c1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1nc[nH]c1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)CC(=O)O)CCC(=O)O)CCCNC(=N)N)CCC(=O)O)CCSC)CO)CC(=O)N)Cc1nc[nH]c1)CC(=O)N)C	negative	training
Tertatolol	S1c2c(CCC1)cccc2OC[C@@H](O)CNC(C)(C)C	negative	training
Testolactone	O1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=CC(=O)C=C4)CC3)C)CC2)CCC1=O)C	negative	training
Testosterone	O[C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C	positive	training
Tetrabenazine	O=C1[C@H](CN2[C@@H](C1)c1c(CC2)cc(OC)c(OC)c1)CC(C)C	negative	training
Tetrachloroethane	C(C(Cl)Cl)(Cl)Cl	positive	external
Tetrachloroethylene	ClC(=C(Cl)Cl)Cl	positive	training
Tetracycline	O[C@@]12[C@@H](C[C@@H]3[C@](O)(c4c(C(=C3C1=O)O)c(O)ccc4)C)[C@H](N(C)C)C(=O)/C(=C(/O)\N)/C2=O	positive	training
Tetrahydrozoline	N1C(=NCC1)[C@H]1CCCc2c1cccc2	negative	training
Thalidomide	O=C1NC(=O)CC[C@@H]1N1C(=O)c2c(C1=O)cccc2	positive	training
Theophylline	O=c1n(c(=O)n(c2nc[nH]c12)C)C	negative	black|NE
Thiabendazole	s1cc(nc1)c1[nH]c2c(n1)cccc2	positive	training
Thiamine	s1c(c([n+](Cc2c(nc(nc2)C)N)c1)C)CCO	negative	black|NE
Thiethylperazine	S1c2c(N(CCCN3CCN(CC3)C)c3c1cccc3)cc(SCC)cc2	positive	training
Thioguanine	S=c1nc([nH]c2nc[nH]c12)N	positive	training
Thiopental	S=C1NC(=O)C([C@@H](CCC)C)(CC)C(=O)N1	positive	training
Thiophenol	Sc1ccccc1	positive	training
Thioridazine	S1c2c(N(CC[C@H]3N(CCCC3)C)c3c1cccc3)cc(SC)cc2	positive	external
Thiotepa	S=P(N1CC1)(N1CC1)N1CC1	negative	training
Thiothixene	S(=O)(=O)(N(C)C)c1cc2/C(=C\CCN3CCN(CC3)C)/c3c(Sc2cc1)cccc3	positive	training
Thyroglobulin	Ic1cc(C[C@H](N)C(=O)O)cc(I)c1Oc1cc(I)c(O)c(I)c1	negative	external
Thyrotropin	O=C(N1[C@@H](CCC1)C(=O)N)[C@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1	negative	training
Tiagabine	s1c(/C(=C\CCN2C[C@@H](CCC2)C(=O)O)/c2sccc2C)c(cc1)C	negative	training
Tiaprofenic	s1c([C@@H](C)C(=O)O)ccc1C(=O)c1ccccc1	positive	training
Tibolone	O[C@@]1([C@@]2([C@H]([C@H]3[C@H](CC2)C2=C(C[C@H]3C)CC(=O)CC2)CC1)C)C#C	negative	training
Ticarcillin	S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@@H](c1ccsc1)C(=O)O	negative	training
Ticlopidine	Clc1c(CN2CCc3sccc3C2)cccc1	positive	training
Ticrynafen	Clc1c(ccc(OCC(=O)O)c1Cl)C(=O)c1sccc1	positive	black|NE
Tigecycline	O[C@@]12[C@@H](C[C@H]3C(=C(O)c4c(C3)c(N(C)C)cc(NC(=O)CNC(C)(C)C)c4O)C1=O)[C@H](N(C)C)C(=O)/C(=C(/O)\N)/C2=O	positive	training
Tiludronate	Clc1ccc(SC(P(=O)(O)O)P(=O)(O)O)cc1	negative	training
Timolol	s1nc(N2CCOCC2)c(OC[C@@H](O)CNC(C)(C)C)n1	negative	training
Tioconazole	Clc1c([C@@H](OCc2ccsc2Cl)Cn2ccnc2)ccc(Cl)c1	negative	training
Tiopronin	S[C@@H](C(=O)NCC(=O)O)C	positive	training
Tiotropium	s1c([C@@](O)(C(=O)O[C@H]2C[C@@H]3[N+]([C@@H]([C@@H]4O[C@H]34)C2)(C)C)c2sccc2)ccc1	negative	training
Tirilazad	O=C([C@@H]1[C@@]2([C@H]([C@H]3C(=CC2)[C@@]2(C(=CC(=O)C=C2)CC3)C)C[C@H]1C)C)CN1CCN(CC1)c1nc(N2CCCC2)nc(N2CCCC2)c1	positive	training
Tirofiban	S(=O)(=O)(N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O)CCCC	negative	training
Tizanidine	Clc1c(NC2=NCCN2)c2nsnc2cc1	positive	training
Tobramycin	O([C@@H]1[C@@H](O)[C@H](O[C@H]2O[C@@H]([C@@H](O)C[C@H]2N)CN)[C@@H](N)C[C@H]1N)[C@H]1O[C@@H]([C@@H](O)[C@H](N)[C@H]1O)CO	positive	external
Tolazamide	S(=O)(=O)(NC(=O)NN1CCCCCC1)c1ccc(cc1)C	positive	training
Tolazoline	N1C(=NCC1)Cc1ccccc1	positive	training
Tolbutamide	S(=O)(=O)(NC(=O)NCCCC)c1ccc(cc1)C	positive	training
Tolcapone	O=C(c1cc(N(=O)=O)c(O)c(O)c1)c1ccc(cc1)C	positive	black|NE
Tolmetin	O=C(c1n(c(cc1)CC(=O)O)C)c1ccc(cc1)C	positive	external
Tolrestat	S=C(N(CC(=O)O)C)c1c2c(c(c(OC)cc2)C(F)(F)F)ccc1	positive	external
Tolterodine	Oc1c([C@@H](CCN(C(C)C)C(C)C)c2ccccc2)cc(cc1)C	positive	training
Topiramate	S(=O)(=O)(OC[C@]12OC[C@H]3OC(O[C@H]3[C@@H]2OC(O1)(C)C)(C)C)N	positive	training
Topotecan	O1Cc2c([C@@](O)(CC)C1=O)cc1n(Cc3c1nc1c(c3)c(CN(C)C)c(O)cc1)c2=O	positive	training
Toremifene	ClCC/C(=C(/c1ccc(OCCN(C)C)cc1)\c1ccccc1)/c1ccccc1	positive	training
Torsemide	S(=O)(=O)(NC(=O)NC(C)C)c1c(Nc2cc(ccc2)C)ccnc1	negative	training
Tramadol	O[C@]1([C@H](CCCC1)CN(C)C)c1cc(OC)ccc1	positive	training
Trandolapril	O=C(N1[C@@H]2[C@@H](C[C@H]1C(=O)O)CCCC2)[C@@H](N[C@@H](CCc1ccccc1)C(=O)OCC)C	negative	training
Tranexamic acid	OC(=O)[C@H]1CC[C@@H](CC1)CN	negative	training
Tranilast	O(c1cc(ccc1OC)/C=C/C(=O)Nc1c(cccc1)C(=O)O)C	positive	training
Tranylcypromine	N[C@H]1[C@@H](C1)c1ccccc1	positive	pairs
Travoprost	FC(F)(F)c1cc(OC[C@H](O)/C=C/[C@@H]2[C@H]([C@@H](O)C[C@H]2O)C/C=C\CCCC(=O)OC(C)C)ccc1	negative	training
Trazodone	Clc1cc(N2CCN(CC2)CCCn2nc3n(c2=O)cccc3)ccc1	positive	training
Treprostinil	O[C@@H]1[C@H]([C@H]2[C@@H](C1)Cc1c(C2)cccc1OCC(=O)O)CC[C@H](O)CCCCC	negative	training
Tretinoin	OC(=O)/C=C(/C=C/C=C(/C=C/C1=C(CCCC1(C)C)C)\C)\C	positive	training
Triazolam	Clc1cc2c(n3c(nnc3C)CN=C2c2c(Cl)cccc2)cc1	positive	training
Trichlormethiazide	ClC(Cl)[C@H]1NS(=O)(=O)c2c(N1)cc(Cl)c(S(=O)(=O)N)c2	negative	external
Trichloroethylene	ClC(=CCl)Cl	positive	training
Tridihexethyl chloride	O[C@@](C1CCCCC1)(CC[N+](CC)(CC)CC)c1ccccc1	negative	training
Trientine	N(CCNCCN)CCN	negative	training
Trifluoperazine	S1c2c(N(CCCN3CCN(CC3)C)c3c1cccc3)cc(cc2)C(F)(F)F	positive	training
Triflupromazine	S1c2c(N(CCCN(C)C)c3c1cccc3)cc(cc2)C(F)(F)F	positive	external
Trifluridine	FC(F)(F)c1cn([C@@H]2O[C@@H]([C@@H](O)C2)CO)c(=O)[nH]c1=O	negative	training
Trihexyphenidyl	O[C@@](C1CCCCC1)(CCN1CCCCC1)c1ccccc1	negative	training
Trilostane	O1[C@@]23[C@@]([C@@H]4[C@H]([C@H]5[C@](CC4)([C@@H](O)CC5)C)CC3)(CC(=C(O)[C@@H]12)C#N)C	negative	external
Trimeprazine	S1c2c(N(C[C@@H](CN(C)C)C)c3c1cccc3)cccc2	positive	training
Trimethadione	O1C(C(=O)N(C1=O)C)(C)C	positive	training
Trimethaphan	[S@@+]12[C@@H]([C@@H]3N(C(=O)N([C@@H]3C1)Cc1ccccc1)Cc1ccccc1)CCC2	negative	training
Trimethobenzamide	O(CCN(C)C)c1ccc(CNC(=O)c2cc(OC)c(OC)c(OC)c2)cc1	positive	training
Trimethoprim	O(c1cc(Cc2c(nc(nc2)N)N)cc(OC)c1OC)C	positive	training
Trimetrexate	O(c1cc(NCc2c(c3c(nc(nc3N)N)cc2)C)cc(OC)c1OC)C	positive	training
Trimipramine	N1(C[C@@H](CN(C)C)C)c2c(CCc3c1cccc3)cccc2	positive	training
Trioxsalen	o1c2c(cc3c(oc(=O)cc3C)c2C)cc1C	negative	training
Tripelennamine	N(CCN(C)C)(Cc1ccccc1)c1ncccc1	negative	training
Triprolidine	N1(CCCC1)C/C=C(\c1ccc(cc1)C)/c1ncccc1	negative	training
Triptorelin	O=C(N1[C@@H](CCC1)C(=O)NCC(=O)N)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)Cc1[nH]cnc1)Cc1c2c([nH]c1)cccc2)CO)Cc1ccc(O)cc1)Cc1c2c([nH]c1)cccc2)CC(C)C)CCCN=C(N)N	negative	training
Troglitazone	S1[C@@H](Cc2ccc(OC[C@]3(Oc4c(CC3)c(c(O)c(c4C)C)C)C)cc2)C(=O)NC1=O	positive	black|NE
Troleandomycin	O1[C@]2(C[C@@H]([C@H](O[C@@H]3O[C@@H](C[C@H](N(C)C)[C@H]3OC(=O)C)C)[C@H]([C@H](O[C@@H]3O[C@H]([C@H](OC(=O)C)[C@@H](OC)C3)C)[C@H](C(=O)O[C@@H]([C@@H]([C@@H](OC(=O)C)[C@H](C2=O)C)C)C)C)C)C)C1	positive	training
Tromethamine	OCC(N)(CO)CO	positive	training
Tropicamide	O=C(N(Cc1ccncc1)CC)[C@@H](c1ccccc1)CO	negative	training
Tropisetron	O([C@H]1C[C@@H]2N([C@@H](CC2)C1)C)C(=O)c1c2c([nH]c1)cccc2	positive	external
Trospium	O([C@H]1C[C@@H]2[N+]3([C@@H](CC2)C1)CCCC3)C(=O)[C@](O)(c1ccccc1)c1ccccc1	negative	training
Trovafloxacin	Fc1c(N2C[C@H]3[C@H]([C@H]3N)C2)nc2n(cc(c(=O)c2c1)C(=O)O)c1c(F)cc(F)cc1	positive	black|NE
Trypan blue	S(=O)(=O)(O)C1=Cc2c(c(N)cc(S(=O)(=O)O)c2)C(=O)/C/1=N/Nc1c(cc(c2cc(c(N/N=C/3\C(=Cc4c(c(N)cc(S(=O)(=O)O)c4)C3=O)S(=O)(=O)O)cc2)C)cc1)C	negative	training
Tubocurarine	O1c2c3[C@H]([N+](CCc3cc(OC)c2O)(C)C)Cc2cc(Oc3cc4[C@@H](N(CCc4cc3OC)C)Cc3ccc1cc3)c(O)cc2	negative	external
Tyropanoate sodium	Ic1c(C[C@@H](CC)C(=O)O)c(I)cc(I)c1NC(=O)CCC	negative	training
Unoprostone	O[C@H]1[C@@H]([C@H]([C@@H](O)C1)C/C=C/CCCC(=O)O)CCC(=O)CCCCCCC	negative	training
Urea	O=C(N)N	negative	external
Urofollitropin	S1SC[C@H](N)C(=O)N[C@@H](C(=O)N[C@@H]([C@@H](CC)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)C1)CC(=O)N)[C@H](O)C)Cc1ccc(O)cc1	negative	training
Ursodiol	O[C@@H]1[C@H]2[C@H]3[C@@]([C@H](CC3)[C@@H](CCC(=O)O)C)(CC[C@@H]2[C@@]2([C@H](C1)C[C@H](O)CC2)C)C	negative	pairs
Usnic acid	O1C2=CC(=O)[C@H](C(=O)[C@]2(c2c1c(c(O)c(c2O)C)C(=O)C)C)C(=O)C	positive	training
Valacyclovir	O(C(=O)[C@@H](N)C(C)C)CCOCn1c2[nH]c(nc(=O)c2nc1)N	positive	training
Valganciclovir	O([C@@H](COC(=O)[C@@H](N)C(C)C)CO)Cn1c2[nH]c(nc(=O)c2nc1)N	negative	training
Valproic acid	OC(=O)C(CCC)CCC	positive	black|NE
Valrubicin	FC(F)(F)C(=O)N[C@H]1C[C@@H](O[C@H]2C[C@@](O)(Cc3c2c(O)c2c(c3O)C(=O)c3c(C2=O)c(OC)ccc3)C(=O)COC(=O)CCCC)O[C@@H]([C@H]1O)C	negative	training
Valsartan	OC(=O)[C@@H](N(Cc1ccc(cc1)c1c(cccc1)c1n[nH]nn1)C(=O)CCCC)C(C)C	positive	training
Vancomycin	Clc1c2Oc3c(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H]([C@@H](O)[C@@](N)(C4)C)C)CO)c4Oc5c(Cl)cc([C@@H](O)[C@@H]6NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC)CC(C)C)[C@H](O)c(c1)cc2)CC(=O)N)c(c3)c4)c1cc(c2c([C@H](NC6=O)C(=O)O)cc(O)cc2O)c(O)cc1)cc5	negative	training
Vardenafil	S(=O)(=O)(N1CCN(CC1)CC)c1cc(c(OCC)cc1)c1[nH]n2c(nc(c2c(=O)n1)C)CCC	positive	training
Varenicline	N1C[C@H]2C[C@H](c3c2cc2nccnc2c3)C1	negative	training
Vecuronium	O([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@@H](CC3)C[C@H](OC(=O)C)[C@@H](N3CCCCC3)C4)C)CC2)C[C@@H]1[N+]1(CCCCC1)C)C)C(=O)C	negative	training
Venlafaxine	OC1([C@@H](CN(C)C)c2ccc(OC)cc2)CCCCC1	positive	training
Verapamil	O(c1cc([C@@](C(C)C)(CCCN(CCc2cc(OC)c(OC)cc2)C)C#N)ccc1OC)C	positive	external
Verteporfin	O(C(=O)[C@H]1[C@@]2(C(=CC=C1C(=O)OC)C1=N/C/2=C\c2[nH]c(c(c2C)CCC(=O)OC)/C=C/2\N=C(/C=c/3\[nH]/c(=C\1)/c(c3C=C)C)C(=C2CCC(=O)O)C)C)C	positive	training
Vesnarinone	O=C(N1CCN(CC1)c1cc2CCC(=O)Nc2cc1)c1cc(OC)c(OC)cc1	positive	training
Vidarabine	O1[C@@H](n2c3ncnc(N)c3nc2)[C@@H](O)[C@H](O)[C@H]1CO	positive	pairs
Vigabatrin	OC(=O)CC[C@H](N)C=C	positive	training
Vinblastine	O([C@@H]1[C@]2([C@@H]3N(CC[C@@]43[C@@H](N(c3c4cc(c(OC)c3)[C@]3(C[C@@H]4C[C@](O)(CN(C4)CCc4c3[nH]c3c4cccc3)CC)C(=O)OC)C)[C@@]1(O)C(=O)OC)CC=C2)CC)C(=O)C	positive	training
Vincristine	O([C@@H]1[C@]2([C@@H]3N(CC[C@@]43[C@@H](N(c3c4cc(c(OC)c3)[C@]3(C[C@H]4C[C@](O)(CN(C4)CCc4c3[nH]c3c4cccc3)CC)C(=O)OC)C=O)[C@@]1(O)C(=O)OC)CC=C2)CC)C(=O)C	positive	training
Vinorelbine	O([C@@H]1[C@]2([C@@H]3N(CC[C@@]43[C@@H](N(c3c4cc(c(OC)c3)[C@]3(C[C@H]4CN(Cc5c3[nH]c3c5cccc3)CC(=C4)CC)C(=O)OC)C)[C@@]1(O)C(=O)OC)CC=C2)CC)C(=O)C	positive	training
Vinylidene chloride	ClC(=C)Cl	positive	training
Vitamin a	OC/C=C(/C=C/C=C(/C=C/C1=C(CCCC1(C)C)C)\C)\C	positive	training
Vitamin d	O[C@@H]1C/C(=C/C=C\2/[C@H]3[C@@]([C@H](CC3)[C@@H](CCCC(C)C)C)(CCC2)C)/C(=C)CC1	negative	training
Voglibose	O[C@@]1(C[C@H](NC(CO)CO)[C@H](O)[C@@H](O)[C@@H]1O)CO	positive	training
Voriconazole	Fc1c([C@](O)([C@@H](C)c2ncncc2F)Cn2ncnc2)ccc(F)c1	positive	training
Vorinostat	O=C(Nc1ccccc1)CCCCCCC(=O)NO	negative	training
Warfarin	o1c(O)c([C@@H](CC(=O)C)c2ccccc2)c(=O)c2c1cccc2	positive	training
Xanomeline	s1nc(C2=CCCN(C2)C)c(OCCCCCC)n1	positive	training
Ximelagatran	O=C(N1[C@@H](CC1)C(=O)NCc1ccc(cc1)/C(=N/O)/N)[C@H](NCC(=O)OCC)C1CCCCC1	positive	black|NE
Xylose	O1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C1	negative	training
Zafirlukast	S(=O)(=O)(NC(=O)c1cc(OC)c(Cc2c3c(n(c2)C)ccc(NC(=O)OC2CCCC2)c3)cc1)c1c(cccc1)C	positive	training
Zalcitabine	O1[C@@H](n2ccc(nc2=O)N)CC[C@H]1CO	positive	training
Zaleplon	O=C(N(c1cc(c2n3ncc(c3ncc2)C#N)ccc1)CC)C	negative	training
Zanamivir	O1[C@H]([C@H](NC(=O)C)[C@@H](N=C(N)N)C=C1C(=O)O)[C@H](O)[C@H](O)CO	negative	training
Ziconotide	S(CC[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](N)CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(O)cc1)CC(=O)O)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC3=O)[C@H](O)C)CO)CSSC2)CCCNC(=N)N)CO)CCCCN)C(=O)N)CCCCN)CCCCN)C)CCCCN)CO)CCCNC(=N)N)CC(C)C)C	positive	training
Zidovudine	O1[C@@H](n2cc(c(=O)[nH]c2=O)C)C[C@H](N=N#N)[C@H]1CO	positive	training
Zileuton	s1c([C@H](N(O)C(=O)N)C)cc2c1cccc2	positive	black|NE
Ziprasidone	Clc1c(CCN2CCN(CC2)c2nsc3c2cccc3)cc2c(NC(=O)C2)c1	positive	training
Zofenopril	S([C@H]1C[C@H](N(C1)C(=O)[C@@H](CSC(=O)c1ccccc1)C)C(=O)O)c1ccccc1	positive	training
Zolmitriptan	O1C[C@@H](NC1=O)Cc1cc2c(CCN(C)C)c[nH]c2cc1	negative	training
Zolpidem	O=C(N(C)C)Cc1n2c(nc1c1ccc(cc1)C)ccc(c2)C	positive	training
Zonisamide	S(=O)(=O)(N)Cc1noc2c1cccc2	positive	training
Zopiclone	Clc1ccc(N2[C@H](OC(=O)N3CCN(CC3)C)c3nccnc3C2=O)nc1	negative	training
